{"cells":[{"cell_type":"markdown","metadata":{"id":"1TkewuBWR765"},"source":["# Plotting data\n","\n","* GWAS\n","* PharmGKB\n","* UK Biobank"]},{"cell_type":"code","execution_count":1,"metadata":{"executionInfo":{"elapsed":447,"status":"ok","timestamp":1699436092364,"user":{"displayName":"Gemma Turon","userId":"16230368266280330675"},"user_tz":-60},"id":"_l3F0-0U4j76"},"outputs":[],"source":["import pandas as pd\n","import numpy as np\n","import os\n","import matplotlib.pyplot as plt\n","\n","DATAPATH = \"../data\""]},{"cell_type":"markdown","metadata":{"id":"hoGpXv-wXtla"},"source":["## GWAS\n","\n","Data source: The ancestry file available for download from the GWAS Catalog (downloaded on the 29th October 2023)"]},{"cell_type":"code","execution_count":41,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":2511,"status":"ok","timestamp":1699436108833,"user":{"displayName":"Gemma Turon","userId":"16230368266280330675"},"user_tz":-60},"id":"iDN9cbmy5Ju6","outputId":"21e22a51-2abf-4bd3-867e-b2e4e6b43d78"},"outputs":[{"data":{"text/plain":["(124224, 12)"]},"execution_count":41,"metadata":{},"output_type":"execute_result"}],"source":["df = pd.read_csv(os.path.join(DATAPATH, \"gwas_catalog-ancestry_r2023-10-29.tsv\"), delimiter='\\t')\n","df.shape"]},{"cell_type":"code","execution_count":42,"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":490},"executionInfo":{"elapsed":786,"status":"ok","timestamp":1699436111577,"user":{"displayName":"Gemma Turon","userId":"16230368266280330675"},"user_tz":-60},"id":"zI00wXQo6LxS","outputId":"40a3cb85-8dcd-417e-d329-77b8f5f9de21"},"outputs":[{"data":{"text/html":["<div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>PUBMEDID</th>\n","      <th>FIRST AUTHOR</th>\n","      <th>DATE</th>\n","      <th>INITIAL SAMPLE DESCRIPTION</th>\n","      <th>REPLICATION SAMPLE DESCRIPTION</th>\n","      <th>STAGE</th>\n","      <th>NUMBER OF INDIVDUALS</th>\n","      <th>BROAD ANCESTRAL CATEGORY</th>\n","      <th>COUNTRY OF ORIGIN</th>\n","      <th>COUNTRY OF RECRUITMENT</th>\n","      <th>ADDITONAL ANCESTRY DESCRIPTION</th>\n","    </tr>\n","    <tr>\n","      <th>STUDY ACCESSION</th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>GCST000001</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>GCST000002</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>2</td>\n","      <td>5</td>\n","      <td>3</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>GCST000003</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>2</td>\n","      <td>4</td>\n","      <td>3</td>\n","      <td>1</td>\n","      <td>3</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>GCST000004</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>2</td>\n","      <td>2</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>2</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>GCST000005</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>...</th>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","    </tr>\n","    <tr>\n","      <th>GCST90296323</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","      <td>1</td>\n","      <td>2</td>\n","      <td>2</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>GCST90296324</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","      <td>1</td>\n","      <td>2</td>\n","      <td>2</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>GCST90296325</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","      <td>1</td>\n","      <td>2</td>\n","      <td>2</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>GCST90296326</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>GCST90296327</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","  </tbody>\n","</table>\n","<p>84961 rows × 11 columns</p>\n","</div>"],"text/plain":["                 PUBMEDID  FIRST AUTHOR  DATE  INITIAL SAMPLE DESCRIPTION  \\\n","STUDY ACCESSION                                                             \n","GCST000001              1             1     1                           1   \n","GCST000002              1             1     1                           1   \n","GCST000003              1             1     1                           1   \n","GCST000004              1             1     1                           1   \n","GCST000005              1             1     1                           1   \n","...                   ...           ...   ...                         ...   \n","GCST90296323            1             1     1                           1   \n","GCST90296324            1             1     1                           1   \n","GCST90296325            1             1     1                           1   \n","GCST90296326            1             1     1                           1   \n","GCST90296327            1             1     1                           1   \n","\n","                 REPLICATION SAMPLE DESCRIPTION  STAGE  NUMBER OF INDIVDUALS  \\\n","STUDY ACCESSION                                                                \n","GCST000001                                    0      1                     1   \n","GCST000002                                    1      2                     5   \n","GCST000003                                    1      2                     4   \n","GCST000004                                    1      2                     2   \n","GCST000005                                    0      1                     1   \n","...                                         ...    ...                   ...   \n","GCST90296323                                  0      1                     2   \n","GCST90296324                                  0      1                     2   \n","GCST90296325                                  0      1                     2   \n","GCST90296326                                  0      1                     1   \n","GCST90296327                                  0      1                     1   \n","\n","                 BROAD ANCESTRAL CATEGORY  COUNTRY OF ORIGIN  \\\n","STUDY ACCESSION                                                \n","GCST000001                              1                  1   \n","GCST000002                              3                  1   \n","GCST000003                              3                  1   \n","GCST000004                              1                  1   \n","GCST000005                              1                  1   \n","...                                   ...                ...   \n","GCST90296323                            2                  1   \n","GCST90296324                            2                  1   \n","GCST90296325                            2                  1   \n","GCST90296326                            1                  1   \n","GCST90296327                            1                  1   \n","\n","                 COUNTRY OF RECRUITMENT  ADDITONAL ANCESTRY DESCRIPTION  \n","STUDY ACCESSION                                                          \n","GCST000001                            1                               0  \n","GCST000002                            1                               0  \n","GCST000003                            3                               0  \n","GCST000004                            2                               0  \n","GCST000005                            1                               0  \n","...                                 ...                             ...  \n","GCST90296323                          1                               0  \n","GCST90296324                          1                               0  \n","GCST90296325                          1                               0  \n","GCST90296326                          1                               0  \n","GCST90296327                          1                               0  \n","\n","[84961 rows x 11 columns]"]},"execution_count":42,"metadata":{},"output_type":"execute_result"}],"source":["df.groupby(\"STUDY ACCESSION\").nunique()"]},{"cell_type":"code","execution_count":43,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":320,"status":"ok","timestamp":1699436122670,"user":{"displayName":"Gemma Turon","userId":"16230368266280330675"},"user_tz":-60},"id":"Q8GuWrpi51Ti","outputId":"87f1aeee-5ef8-4af2-fcde-b1f9d2b56e2d"},"outputs":[{"data":{"text/plain":["(101421, 12)"]},"execution_count":43,"metadata":{},"output_type":"execute_result"}],"source":["# We eliminate studies that are replicates\n","df2 = df[df[\"STAGE\"]!= \"replication\"]\n","df2.shape"]},{"cell_type":"code","execution_count":44,"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":490},"executionInfo":{"elapsed":282,"status":"ok","timestamp":1699436137629,"user":{"displayName":"Gemma Turon","userId":"16230368266280330675"},"user_tz":-60},"id":"l0mvOwDzSWHO","outputId":"685374dd-2714-4362-bfc4-90d296366fc0"},"outputs":[{"data":{"text/html":["<div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>PUBMEDID</th>\n","      <th>FIRST AUTHOR</th>\n","      <th>DATE</th>\n","      <th>INITIAL SAMPLE DESCRIPTION</th>\n","      <th>REPLICATION SAMPLE DESCRIPTION</th>\n","      <th>STAGE</th>\n","      <th>NUMBER OF INDIVDUALS</th>\n","      <th>BROAD ANCESTRAL CATEGORY</th>\n","      <th>COUNTRY OF ORIGIN</th>\n","      <th>COUNTRY OF RECRUITMENT</th>\n","      <th>ADDITONAL ANCESTRY DESCRIPTION</th>\n","    </tr>\n","    <tr>\n","      <th>STUDY ACCESSION</th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","      <th></th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>GCST000001</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>GCST000002</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>3</td>\n","      <td>3</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>GCST000003</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>GCST000004</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>GCST000005</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>...</th>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","    </tr>\n","    <tr>\n","      <th>GCST90296323</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","      <td>1</td>\n","      <td>2</td>\n","      <td>2</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>GCST90296324</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","      <td>1</td>\n","      <td>2</td>\n","      <td>2</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>GCST90296325</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","      <td>1</td>\n","      <td>2</td>\n","      <td>2</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>GCST90296326</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>GCST90296327</th>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>1</td>\n","      <td>0</td>\n","    </tr>\n","  </tbody>\n","</table>\n","<p>84959 rows × 11 columns</p>\n","</div>"],"text/plain":["                 PUBMEDID  FIRST AUTHOR  DATE  INITIAL SAMPLE DESCRIPTION  \\\n","STUDY ACCESSION                                                             \n","GCST000001              1             1     1                           1   \n","GCST000002              1             1     1                           1   \n","GCST000003              1             1     1                           1   \n","GCST000004              1             1     1                           1   \n","GCST000005              1             1     1                           1   \n","...                   ...           ...   ...                         ...   \n","GCST90296323            1             1     1                           1   \n","GCST90296324            1             1     1                           1   \n","GCST90296325            1             1     1                           1   \n","GCST90296326            1             1     1                           1   \n","GCST90296327            1             1     1                           1   \n","\n","                 REPLICATION SAMPLE DESCRIPTION  STAGE  NUMBER OF INDIVDUALS  \\\n","STUDY ACCESSION                                                                \n","GCST000001                                    0      1                     1   \n","GCST000002                                    1      1                     3   \n","GCST000003                                    1      1                     1   \n","GCST000004                                    1      1                     1   \n","GCST000005                                    0      1                     1   \n","...                                         ...    ...                   ...   \n","GCST90296323                                  0      1                     2   \n","GCST90296324                                  0      1                     2   \n","GCST90296325                                  0      1                     2   \n","GCST90296326                                  0      1                     1   \n","GCST90296327                                  0      1                     1   \n","\n","                 BROAD ANCESTRAL CATEGORY  COUNTRY OF ORIGIN  \\\n","STUDY ACCESSION                                                \n","GCST000001                              1                  1   \n","GCST000002                              3                  1   \n","GCST000003                              1                  1   \n","GCST000004                              1                  1   \n","GCST000005                              1                  1   \n","...                                   ...                ...   \n","GCST90296323                            2                  1   \n","GCST90296324                            2                  1   \n","GCST90296325                            2                  1   \n","GCST90296326                            1                  1   \n","GCST90296327                            1                  1   \n","\n","                 COUNTRY OF RECRUITMENT  ADDITONAL ANCESTRY DESCRIPTION  \n","STUDY ACCESSION                                                          \n","GCST000001                            1                               0  \n","GCST000002                            1                               0  \n","GCST000003                            1                               0  \n","GCST000004                            1                               0  \n","GCST000005                            1                               0  \n","...                                 ...                             ...  \n","GCST90296323                          1                               0  \n","GCST90296324                          1                               0  \n","GCST90296325                          1                               0  \n","GCST90296326                          1                               0  \n","GCST90296327                          1                               0  \n","\n","[84959 rows x 11 columns]"]},"execution_count":44,"metadata":{},"output_type":"execute_result"}],"source":["df2.groupby(\"STUDY ACCESSION\").nunique()"]},{"cell_type":"code","execution_count":23,"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":213},"executionInfo":{"elapsed":8,"status":"ok","timestamp":1699436174985,"user":{"displayName":"Gemma Turon","userId":"16230368266280330675"},"user_tz":-60},"id":"v8v2dOrJSbJb","outputId":"fa150da5-7a19-49ff-e82f-b8d7abf423e5"},"outputs":[{"data":{"text/html":["<div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>STUDY ACCESSION</th>\n","      <th>PUBMEDID</th>\n","      <th>FIRST AUTHOR</th>\n","      <th>DATE</th>\n","      <th>INITIAL SAMPLE DESCRIPTION</th>\n","      <th>REPLICATION SAMPLE DESCRIPTION</th>\n","      <th>STAGE</th>\n","      <th>NUMBER OF INDIVDUALS</th>\n","      <th>BROAD ANCESTRAL CATEGORY</th>\n","      <th>COUNTRY OF ORIGIN</th>\n","      <th>COUNTRY OF RECRUITMENT</th>\n","      <th>ADDITONAL ANCESTRY DESCRIPTION</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>9527</th>\n","      <td>GCST000002</td>\n","      <td>16252231</td>\n","      <td>Maraganore DM</td>\n","      <td>2005-09-09</td>\n","      <td>381 European ancestry cases, 363 European ance...</td>\n","      <td>269 European ancestry cases, 272 European ance...</td>\n","      <td>initial</td>\n","      <td>744.0</td>\n","      <td>European</td>\n","      <td>NR</td>\n","      <td>U.S.</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>9530</th>\n","      <td>GCST000002</td>\n","      <td>16252231</td>\n","      <td>Maraganore DM</td>\n","      <td>2005-09-09</td>\n","      <td>381 European ancestry cases, 363 European ance...</td>\n","      <td>269 European ancestry cases, 272 European ance...</td>\n","      <td>initial</td>\n","      <td>1.0</td>\n","      <td>Asian unspecified</td>\n","      <td>NR</td>\n","      <td>U.S.</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>9531</th>\n","      <td>GCST000002</td>\n","      <td>16252231</td>\n","      <td>Maraganore DM</td>\n","      <td>2005-09-09</td>\n","      <td>381 European ancestry cases, 363 European ance...</td>\n","      <td>269 European ancestry cases, 272 European ance...</td>\n","      <td>initial</td>\n","      <td>141.0</td>\n","      <td>Other</td>\n","      <td>NR</td>\n","      <td>U.S.</td>\n","      <td>NaN</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>"],"text/plain":["     STUDY ACCESSION  PUBMEDID   FIRST AUTHOR        DATE  \\\n","9527      GCST000002  16252231  Maraganore DM  2005-09-09   \n","9530      GCST000002  16252231  Maraganore DM  2005-09-09   \n","9531      GCST000002  16252231  Maraganore DM  2005-09-09   \n","\n","                             INITIAL SAMPLE DESCRIPTION  \\\n","9527  381 European ancestry cases, 363 European ance...   \n","9530  381 European ancestry cases, 363 European ance...   \n","9531  381 European ancestry cases, 363 European ance...   \n","\n","                         REPLICATION SAMPLE DESCRIPTION    STAGE  \\\n","9527  269 European ancestry cases, 272 European ance...  initial   \n","9530  269 European ancestry cases, 272 European ance...  initial   \n","9531  269 European ancestry cases, 272 European ance...  initial   \n","\n","      NUMBER OF INDIVDUALS BROAD ANCESTRAL CATEGORY COUNTRY OF ORIGIN  \\\n","9527                 744.0                 European                NR   \n","9530                   1.0        Asian unspecified                NR   \n","9531                 141.0                    Other                NR   \n","\n","     COUNTRY OF RECRUITMENT ADDITONAL ANCESTRY DESCRIPTION  \n","9527                   U.S.                            NaN  \n","9530                   U.S.                            NaN  \n","9531                   U.S.                            NaN  "]},"execution_count":23,"metadata":{},"output_type":"execute_result"}],"source":["# some studies have more than one line depending on the ancestry\n","df2[df2[\"STUDY ACCESSION\"]==\"GCST000002\"]"]},{"cell_type":"code","execution_count":24,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":6,"status":"ok","timestamp":1699436297100,"user":{"displayName":"Gemma Turon","userId":"16230368266280330675"},"user_tz":-60},"id":"VFXOEAYT6fgG","outputId":"befc08c0-ee6c-40ab-fa77-819922cfaabd"},"outputs":[{"data":{"text/plain":["(62000, 12)"]},"execution_count":24,"metadata":{},"output_type":"execute_result"}],"source":["df2[df2[\"BROAD ANCESTRAL CATEGORY\"]==\"European\"].shape"]},{"cell_type":"code","execution_count":55,"metadata":{},"outputs":[{"data":{"text/plain":["(5570, 12)"]},"execution_count":55,"metadata":{},"output_type":"execute_result"}],"source":["df2[df2[\"BROAD ANCESTRAL CATEGORY\"].str.contains(\"NR\")].shape\n","df2[df2[\"BROAD ANCESTRAL CATEGORY\"]==\"NR\"].shape"]},{"cell_type":"code","execution_count":51,"metadata":{},"outputs":[{"name":"stdout","output_type":"stream","text":["['South Asian, European, African American or Afro-Caribbean, East Asian, Hispanic or Latin American', 'African unspecified', 'European, African American or Afro-Caribbean, Hispanic or Latin American, Asian unspecified, Oceanian, NR', 'South East Asian', 'European, Hispanic or Latin American, Other', 'Native American, Other', 'European, Asian unspecified, African American or Afro-Caribbean, Greater Middle Eastern (Middle Eastern, North African or Persian), Oceanian, Native American, Other admixed ancestry', 'African American or Afro-Caribbean, African unspecified, European', 'European, African American or Afro-Caribbean, Hispanic or Latin American, Asian unspecified, Native American, Other', 'South Asian, African unspecified, NR', 'European, South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin American', 'Hispanic or Latin American', 'African American or Afro-Caribbean, African unspecified, European, East Asian, Hispanic or Latin American, South Asian', 'Central Asian, South Asian', 'Asian unspecified, African American or Afro-Caribbean, Oceanian, Native American, NR', 'NR, African American or Afro-Caribbean, European, African unspecified, Asian unspecified, Other', 'East Asian, South Asian, South East Asian', 'African American or Afro-Caribbean, NR', 'Asian unspecified, European, Hispanic or Latin American, NR, South Asian', 'European, Asian unspecified, African American or Afro-Caribbean, Greater Middle Eastern (Middle Eastern, North African or Persian), Oceanian, Native American, Other, Other admixed ancestry', 'African unspecified, Asian unspecified, African American or Afro-Caribbean, Greater Middle Eastern (Middle Eastern, North African or Persian), NR', 'East Asian, Hispanic or Latin American, South Asian, African American or Afro-Caribbean', 'Other, NR', 'European, East Asian, NR', 'African American or Afro-Caribbean, European, Hispanic or Latin American, Oceanian, Asian unspecified, Other', 'European, South Asian, East Asian', 'European, African American or Afro-Caribbean, Native American, Asian unspecified', 'European, Asian unspecified', 'NR, African American or Afro-Caribbean, European, Hispanic or Latin American, East Asian', 'African unspecified, Asian unspecified, European, Other', 'Central Asian', 'European, African unspecified, Hispanic or Latin American, South East Asian, South Asian', 'European, African unspecified, South Asian, East Asian, Native American, Hispanic or Latin American', 'African American or Afro-Caribbean, Sub-Saharan African', 'Asian unspecified', 'African American or Afro-Caribbean, Asian unspecified, European', 'African unspecified, Hispanic or Latin American, European, Asian unspecified, NR', 'Asian unspecified, East Asian', 'European, African American or Afro-Caribbean, Hispanic or Latin American', 'Native American, Hispanic or Latin American', 'African American or Afro-Caribbean, Asian unspecified, European, Hispanic or Latin American, Native American, NR, Other admixed ancestry', 'South Asian, East Asian, African unspecified', 'African American or Afro-Caribbean, European, Hispanic or Latin American, Oceanian, Asian unspecified, Native American, Other', 'European, Asian unspecified, Other', 'European, African unspecified, Hispanic or Latin American, NR', 'NR, European, African unspecified', 'East Asian, Other', 'South Asian, South East Asian, East Asian, Asian unspecified', 'European, African unspecified, Asian unspecified, Hispanic or Latin American, NR', 'South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin American', 'East Asian, Sub-Saharan African, Hispanic or Latin American, European', 'South Asian, East Asian, Asian unspecified, African American or Afro-Caribbean, Hispanic or Latin American', 'African American or Afro-Caribbean, Sub-Saharan African, African unspecified', 'African American or Afro-Caribbean, African unspecified', 'East Asian, South Asian, African American or Afro-Caribbean, Hispanic or Latin American', 'European, Hispanic or Latin American, African unspecified, Asian unspecified, Other', 'European, African American or Afro-Caribbean, Hispanic or Latin American, NR', 'African unspecified, Asian unspecified, European, Native American, NR', 'European, East Asian, South Asian, African unspecified, NR', 'European, South Asian, Asian unspecified, NR', 'African American or Afro-Caribbean, East Asian, European, Hispanic or Latin American, South Asian', 'Hispanic or Latin American, Asian unspecified, Native American, Other', 'NR', 'African American or Afro-Caribbean, African unspecified, Other', 'Hispanic or Latin American, African American or Afro-Caribbean', 'European, Greater Middle Eastern (Middle Eastern, North African or Persian)', 'Asian unspecified, Native American, NR, Oceanian', 'European, Central Asian', 'European, South Asian, African unspecified', 'NR, African American or Afro-Caribbean, European, Asian unspecified', 'Asian unspecified, European, African American or Afro-Caribbean, Greater Middle Eastern (Middle Eastern, North African or Persian), Oceanian, Native American, Other admixed ancestry', 'African American or Afro-Caribbean, Asian unspecified, Native American, NR, Oceanian', 'European, East Asian, Hispanic or Latin American, Other admixed ancestry, South Asian', 'Hispanic or Latin American, European, South Asian', 'Hispanic or Latin American, African unspecified', 'European, East Asian, African American or Afro-Caribbean, Hispanic or Latin American, NR', 'European, Other, Asian unspecified, Greater Middle Eastern (Middle Eastern, North African or Persian)', 'European, African unspecified, East Asian, Native American', 'East Asian, South East Asian, South Asian, Asian unspecified', 'European, Hispanic or Latin American, African unspecified, Asian unspecified', 'Other admixed ancestry, NR', 'European, South Asian, Asian unspecified, African American or Afro-Caribbean, Hispanic or Latin American', 'East Asian, European', 'East Asian, NR', 'European, East Asian', 'East Asian, European, African American or Afro-Caribbean, Hispanic or Latin American', 'NR, Oceanian, Native American', 'European, Other', 'European, NR', 'NR, Native American, Other admixed ancestry', 'Other admixed ancestry', 'NR, Hispanic or Latin American, African unspecified, Asian unspecified', 'African unspecified, Asian unspecified', 'European, South Asian', 'Sub-Saharan African', 'NR, African unspecified, East Asian', 'African American or Afro-Caribbean, European', 'African American or Afro-Caribbean, Asian unspecified, European, Hispanic or Latin American, Native American, Other', 'European, African American or Afro-Caribbean, Hispanic or Latin American, East Asian', 'European, South Asian, African American or Afro-Caribbean, African unspecified', 'European, African unspecified, Asian unspecified, NR', 'European, African unspecified, Other', 'European, African American or Afro-Caribbean, Hispanic or Latin American, Asian unspecified', 'East Asian, South Asian, African American or Afro-Caribbean', 'African American or Afro-Caribbean, Asian unspecified, Other', 'European, African unspecified, South Asian, South East Asian, Central Asian, East Asian, African American or Afro-Caribbean, Greater Middle Eastern (Middle Eastern, North African or Persian), Native American, Other admixed ancestry', 'African American or Afro-Caribbean, European, Hispanic or Latin American, South Asian', 'European, South Asian, East Asian, Hispanic or Latin American, African American or Afro-Caribbean', 'South Asian', 'African American or Afro-Caribbean, European, Asian unspecified, Other', 'European, African American or Afro-Caribbean, African unspecified, East Asian, South Asian, Hispanic or Latin American, Other admixed ancestry', 'African American or Afro-Caribbean, South Asian, European, East Asian, Other, Hispanic or Latin American', 'European, South Asian, Asian unspecified, African American or Afro-Caribbean, Hispanic or Latin American, Other', 'East Asian, South Asian, African unspecified', 'Asian unspecified, Native American, Other', 'African American or Afro-Caribbean, African unspecified, Asian unspecified, European, Hispanic or Latin American, NR', 'African American or Afro-Caribbean, South Asian, European, East Asian, Hispanic or Latin American', 'European, East Asian, Other, Other admixed ancestry', 'African American or Afro-Caribbean, Hispanic or Latin American', 'African American or Afro-Caribbean, Hispanic or Latin American, Other', 'European, African American or Afro-Caribbean, Hispanic or Latin American, Asian unspecified, Other, Native American', 'NR, African American or Afro-Caribbean', 'South East Asian, East Asian', 'East Asian, European, Hispanic or Latin American, South Asian', 'European, East Asian, South Asian, African American or Afro-Caribbean, Hispanic or Latin American', 'Native American, NR, Oceanian', 'Other admixed ancestry, African unspecified, Hispanic or Latin American, East Asian, European, South Asian, South East Asian, NR', 'African American or Afro-Caribbean, European, Hispanic or Latin American, Asian unspecified, NR', 'European, African unspecified', 'Hispanic or Latin American, Other', 'Aboriginal Australian', 'African unspecified, European, Hispanic or Latin American', 'African American or Afro-Caribbean, South Asian, European, East Asian', 'NR, Other admixed ancestry', 'East Asian, South Asian', 'South Asian, Hispanic or Latin American, African unspecified, Asian unspecified, Greater Middle Eastern (Middle Eastern, North African or Persian)', 'European, Hispanic or Latin American, East Asian, African unspecified, South Asian', 'Asian unspecified, Oceanian', 'African American or Afro-Caribbean, Asian unspecified', 'East Asian, Asian unspecified', 'European, Hispanic or Latin American, East Asian, African American or Afro-Caribbean, South Asian', 'European, Hispanic or Latin American, African unspecified', 'African American or Afro-Caribbean, East Asian, South Asian', 'Greater Middle Eastern (Middle Eastern, North African or Persian)', 'Other', 'South Asian, South East Asian, East Asian', 'NR, Hispanic or Latin American', 'East Asian, European, Sub-Saharan African', 'African American or Afro-Caribbean, European, Hispanic or Latin American, Other', 'Native American', 'African American or Afro-Caribbean, European, Hispanic or Latin American', 'European, East Asian, South Asian, Hispanic or Latin American, African unspecified', 'Asian unspecified, European', 'European, African unspecified, NR', 'European, African American or Afro-Caribbean, Native American, NR', 'Hispanic or Latin American, African American or Afro-Caribbean, European', 'South Asian, African unspecified, East Asian, Hispanic or Latin American, Other', 'Oceanian', 'Asian unspecified, African American or Afro-Caribbean, Hispanic or Latin American', 'Asian unspecified, Other', 'African American or Afro-Caribbean, European, NR', 'African unspecified, Sub-Saharan African', 'European, Hispanic or Latin American, Native American', 'European, Hispanic or Latin American, African unspecified, Asian unspecified, Native American, Other', 'African unspecified, Hispanic or Latin American, European, NR', 'European, African unspecified, Hispanic or Latin American', 'African American or Afro-Caribbean, South East Asian, Hispanic or Latin American, Other', 'European, African American or Afro-Caribbean, East Asian, South Asian, Asian unspecified, Hispanic or Latin American', 'East Asian, Asian unspecified, Other', 'Asian unspecified, African American or Afro-Caribbean, Native American, Other admixed ancestry', 'European, Sub-Saharan African', 'European, African American or Afro-Caribbean, East Asian, Hispanic or Latin American', 'African American or Afro-Caribbean, East Asian, Greater Middle Eastern (Middle Eastern, North African or Persian), Hispanic or Latin American, South Asian', 'NR, European, Hispanic or Latin American, African unspecified, Asian unspecified', 'South Asian, Central Asian', 'NR, European', 'European, African unspecified, African American or Afro-Caribbean, Asian unspecified, NR', 'African unspecified, African American or Afro-Caribbean', 'European, East Asian, South East Asian, South Asian, Asian unspecified', 'African American or Afro-Caribbean, East Asian, Hispanic or Latin American, South Asian', 'African unspecified, Asian unspecified, European, NR', 'African American or Afro-Caribbean, Other', 'European, African American or Afro-Caribbean, East Asian, South Asian, Hispanic or Latin American', 'Sub-Saharan African, African unspecified', 'European', 'European, Hispanic or Latin American, Oceanian, African unspecified, Other', 'African unspecified, European, Native American', 'Oceanian, Asian unspecified', 'European, African American or Afro-Caribbean', 'Asian unspecified, European, Hispanic or Latin American, Native American, NR, Oceanian', 'African unspecified, NR', 'European, East Asian, Hispanic or Latin American, African unspecified', 'South Asian, East Asian', 'Sub-Saharan African, African American or Afro-Caribbean', 'African American or Afro-Caribbean, East Asian, European, Hispanic or Latin American, South Asian, Sub-Saharan African', 'East Asian', 'Hispanic or Latin American, NR', 'Native American, East Asian', 'NR, African unspecified', 'European, Sub-Saharan African, Hispanic or Latin American, NR', 'African unspecified, European', 'Hispanic or Latin American, Oceanian, Asian unspecified, Native American', 'NR, Other', 'African unspecified, Hispanic or Latin American', 'African American or Afro-Caribbean, European, Hispanic or Latin American, Asian unspecified', 'European, Hispanic or Latin American', 'African American or Afro-Caribbean, European, Other', 'African American or Afro-Caribbean', 'African American or Afro-Caribbean, Hispanic or Latin American, NR', 'European, African unspecified, Hispanic or Latin American, Native American, South East Asian, East Asian, South Asian', 'European, African American or Afro-Caribbean, NR', 'African American or Afro-Caribbean, East Asian, European, Hispanic or Latin American', 'African American or Afro-Caribbean, East Asian, European, Greater Middle Eastern (Middle Eastern, North African or Persian), Hispanic or Latin American, NR, South Asian, South East Asian', 'African American or Afro-Caribbean, East Asian, Hispanic or Latin American, South East Asian', 'Hispanic or Latin American, Native American', 'South Asian, European']\n"]}],"source":["all_ancestry = list(set(df2[\"BROAD ANCESTRAL CATEGORY\"]))\n","print(all_ancestry)"]},{"cell_type":"code","execution_count":27,"metadata":{},"outputs":[{"data":{"text/plain":["(62818, 12)"]},"execution_count":27,"metadata":{},"output_type":"execute_result"}],"source":["df2[df2[\"BROAD ANCESTRAL CATEGORY\"].str.contains(\"European\")].shape"]},{"cell_type":"code","execution_count":25,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":306,"status":"ok","timestamp":1699436991016,"user":{"displayName":"Gemma Turon","userId":"16230368266280330675"},"user_tz":-60},"id":"8L7SyRYQQVlq","outputId":"fe384886-f9d2-46db-a402-f535e9431b9a"},"outputs":[{"data":{"text/plain":["(18847, 12)"]},"execution_count":25,"metadata":{},"output_type":"execute_result"}],"source":["df2[df2[\"BROAD ANCESTRAL CATEGORY\"].str.contains(\"African\")].shape"]},{"cell_type":"code","execution_count":56,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":402,"status":"ok","timestamp":1699437006335,"user":{"displayName":"Gemma Turon","userId":"16230368266280330675"},"user_tz":-60},"id":"VLJC4r6lUBA3","outputId":"42dd0f4c-65c2-483d-cb65-1ff6c51d7257"},"outputs":[{"name":"stdout","output_type":"stream","text":["76.30952380952381\n","22.89480077745384\n"]}],"source":["# we will take all unique studies (STUDY ACCESSION ID) as total number, removing studies for which no Ancestry data is available\n","# We will use any African-related (i.e, contains \"African\") to define number of studies done in african or african ancestry populations\n","# We will use any European-related (i.e, contains European) to define number of studies done in European populations\n","df2_ = df2[df2[\"BROAD ANCESTRAL CATEGORY\"]!=\"NR\"]\n","total = len(df2_.groupby(\"STUDY ACCESSION\").nunique())\n","afr = len(df2_[df2_[\"BROAD ANCESTRAL CATEGORY\"].str.contains(\"African\")])\n","eur = len(df2_[df2_[\"BROAD ANCESTRAL CATEGORY\"].str.contains(\"European\")])\n","\n","print((eur/total)*100)\n","print((afr/total)*100)"]},{"cell_type":"markdown","metadata":{"id":"c7U-oMU-XxB6"},"source":["## PharmGKB\n","\n","Data Source: the study_parameters file downloadable from PharmGKB which contains the information about the biogroup for which the study was performed (accessed on 10th October 2023)"]},{"cell_type":"code","execution_count":72,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":649,"status":"ok","timestamp":1699437591066,"user":{"displayName":"Gemma Turon","userId":"16230368266280330675"},"user_tz":-60},"id":"igh-jTYHXmu3","outputId":"20eccfb7-1c0b-4422-aeb4-fc7035162d03"},"outputs":[{"data":{"text/plain":["(32076, 3)"]},"execution_count":72,"metadata":{},"output_type":"execute_result"}],"source":["df = pd.read_csv(os.path.join(DATAPATH, \"study_parameters.csv\"))\n","df.shape"]},{"cell_type":"code","execution_count":75,"metadata":{},"outputs":[{"data":{"text/plain":["['Multiple groups, France, Italy, Finland',\n"," 'Multiple groups, Asian and Caucasians were studied',\n"," 'Multiple groups, White, Black, Other',\n"," 'Multiple groups, USA, Colorado. \"The most frequent self-reported race was white (Caucasian) (46.6% [163/350]) and 51.4% (180/350) of participants reported Hispanic or Latina ethnicity.\"',\n"," 'Multiple groups, East-Asians, Caucasians, Hispanics and Blacks',\n"," 'Multiple groups, USA Chicago: Caucasian (n=105), Hispanic (n=4), Asian (n=2), African American (n=1), Native American (n=1), Other (n=1)',\n"," 'Multiple groups, 115 African Americans, 41 Hispanic and 28 white',\n"," 'Multiple groups, Case and control cohorts were \"primarily of European ancestry\"',\n"," 'Multiple groups, Two studies that were mostly Caucasian, ranging from 88% white to >95% white cases and one in Korean Asian cases',\n"," 'Multiple groups, 98% White',\n"," 'Multiple groups, Patients were of Caucasian, Hispanic or African American ethnicity',\n"," 'Multiple groups, 98% white',\n"," 'Multiple groups, \"Urdu Speaking, Sindhi, Pathan, Punjabi, Others\"',\n"," 'Multiple groups, Brazil with African (24%), European (42%) and Native American (34%) ancestry',\n"," 'Multiple groups, whites and hispanics',\n"," 'Multiple groups, mainly white',\n"," 'Multiple groups, 84 participants were white.',\n"," 'Custom, in vitro protein study',\n"," 'Multiple groups, 84% white',\n"," 'Multiple groups, 23 were male, 38 were white, and 15 were nonwhite. The median age was 6 years (range, 0 to 18 years)',\n"," 'Multiple groups, White, non-Latino: 56%;White, Latino:18%;African American: 14%;Other: 12%.',\n"," 'Multiple groups, Souther brazillians',\n"," 'Multiple groups, Ethnicity; Malay, Chinese, Kadazan-Dusun, Bajau.',\n"," 'Multiple groups, White, African-American',\n"," 'Multiple groups, Korean, Chinese, French',\n"," 'Multiple groups, 206 unrelated non-Hispanic women (130 blacks and 76 whites) and 170 unrelated non-Hispanic men (62 blacks and 108 whites)',\n"," 'Multiple groups, Caucasian, black and biracial participants',\n"," 'Multiple groups, Caucasian, African American and Hispanic',\n"," 'Multiple groups, 2 Asian studies and 1 European study',\n"," 'Multiple groups, White/non-Hispanic (n=378); Black/non-Hispanic (n=121); Hispanic (n=112)',\n"," 'Multiple groups, 87% Caucasian',\n"," 'Multiple groups, Primarily white',\n"," 'Multiple groups, Asian and White',\n"," 'Multiple groups, Asian, Middle Eastern, Southern European, Anglo-Celtic Australian',\n"," 'Multiple groups, East Asian (n=111) and Caucasian (n=819)',\n"," 'Multiple groups, Participants were of the following ethnicities: Punjabi, Pathan, Urdu Speaking, Kashmiri and Others',\n"," 'Multiple groups, Portugal: 44 white, 1 African',\n"," 'Multiple groups, Caucasian and African American patients.',\n"," 'Multiple groups, 90% white other races not specified.',\n"," 'Multiple groups, white origin (n = 58 [81.7%]) with a few patients of Arab (n = 5), African (n = 3), Asian (n = 1), or undocumented origin (n = 4).',\n"," 'Multiple groups, Seattle, USA, predominantly White, 1.-3.4% Black.',\n"," 'Multiple groups, 20.1% African American',\n"," 'Multiple groups, Human Variation Panel LCLs and DNA samples.  96 EA; 96 AA; 96 HCA.Freq. of C was 0.49 in AA; 0.59 in EA and 0.77 in HCA.',\n"," 'Multiple groups, German, Austrian, Swiss, French, Italian,',\n"," 'Multiple groups, White (n=92), African (n=1) and Hispanic (n=3)',\n"," \"Multiple groups, White Hispanic, White non-Hispanic, African American, Asian/Pacific Islander, Native American or 'Unknown' ethnicities\",\n"," 'Multiple groups, Black and white patients',\n"," 'Custom, \" Russian\"',\n"," 'Multiple groups, EM:9 Caucasian;1 Chinese (Asian).  PM:2 Caucasian; 5 Chinese and 3 Japanese (8 Asian).',\n"," 'Multiple groups, African American, non-Hispanic Caucasian and Hispanic Caucasian',\n"," 'Multiple groups, Asian (n=126) and Caucasian (n=455)',\n"," 'Multiple groups, Norway',\n"," 'Multiple groups, 72 Caucasian, 7 African-American, 1 Indian',\n"," 'Multiple groups, 95% of the study population was of Caucasian origin',\n"," 'Multiple groups, \"majority of the participants were Caucasians (87%)\"',\n"," nan,\n"," 'Multiple groups, White and African American patients',\n"," 'Multiple groups, European American - mainly White but some Latino/White.',\n"," 'Multiple groups, USA, 89% Caucasian',\n"," 'Multiple groups, European and  US',\n"," 'Multiple groups, residents of mainland U.S. or Puerto Rico.  White,Hispanic,African American,Other.',\n"," 'Multiple groups, Japanese, Caucasian, Korean',\n"," 'Multiple groups, USA, 91% white, 5% black, 2.5% asian, 1.2% hispanic',\n"," 'Multiple groups, White and Hispanic patients',\n"," 'Multiple groups, Majority were White patients',\n"," 'Multiple groups, 75% white, 20% black, 5% asian',\n"," 'Multiple groups, Meta-analysis of Japanese patients from current study combined with results from previous studies in Chinese and European patients.',\n"," 'Multiple groups, USA: 267 Caucasian and 49 African American children',\n"," 'Multiple groups, out of an initial 40 patients(2 of whom did not complete the study), there were 35 Caucasian,2 Maori,2 Fijian Indian and 1 Chinese from the Australian New Zealand Clinical Trials registry.',\n"," 'Multiple groups, 96% Caucasian',\n"," 'Multiple groups, 93.2% white (n = 191), 2.4% Asian (n = 5), 1.0% black (n = 2), and 3.4% other (3 Hindustani, 3 Surinamese, and 1 Israeli)',\n"," 'Multiple groups, Study carried out in London, Ontario, Canada. The majority of study participants were Caucasian.',\n"," 'Multiple groups, INVEST-GENES.  40% White; 48.4 % Hispanic; 11.7% Black.; \"cohort study nested in a randomized trial.\"',\n"," 'Multiple groups, Black, White, Other; St Judes, USA',\n"," 'Multiple groups, White (64); African American (4)',\n"," 'Multiple groups, Caucasian, Black and Asian patients.',\n"," 'Multiple groups, Vandebilt USA: 89.2% White, 9.8% Black, 1% Hispanic',\n"," 'Multiple groups, White, Black, Asian or Hispanic ethnicities',\n"," 'Multiple groups, African -Americans plus European Americans',\n"," 'Multiple groups, Brazilian, 61% White',\n"," 'Multiple groups, Chinese, Indian, Malaysian, Japanese, Korean, Pakistan, Reunion, Vietnam, Cambodia, Senegal, European',\n"," 'Multiple groups, Caucasian, Black/African-American, Asian, Other',\n"," 'Multiple groups, \"Malay, Chinese,\\u2002Indian, Others\"',\n"," 'Multiple groups, 39 men and 36 women; 73 white, 1 Asian, and 1 black African',\n"," 'Multiple groups, mostly Whites and Blacks.',\n"," 'Multiple groups, 93% Caucasian, 7% Indian or unknown',\n"," 'Multiple groups, East Asian (n=299) and Caucasian (n=966)',\n"," 'Multiple groups, \"11 were Caucasian (33,67 %) and 19; were Latin-American (63.33 %).\"',\n"," 'Multiple groups, 84% White',\n"," 'Multiple groups, pooled African American sample plus European American sample.  Nuclear families. MSTF(Mid-South Tobacco Family) cohort.',\n"," 'Multiple groups, Canada.',\n"," 'Multiple groups, 71% White, 27% Asian',\n"," 'Multiple groups, African American and Caucasian',\n"," 'Multiple groups, Mixed population of white and Hispanic (Puerto Rico) subjects',\n"," \"Multiple groups, Participants self-reported as being Chinese, Japanese, 'Other East Asian' and 'Other'\",\n"," 'Multiple groups, Majority Caucasian (72%)',\n"," 'Multiple groups, Of the 1536 TOTAL study participants,; 1362 (88.7%) were self-identified as black, 44 (2.9%) as; Hispanic, 19 (1.2%) as Asian, and 11; (0.7%) as other.',\n"," 'Multiple groups, Canada: Asian, Caucasian, South Asian, Hispanic, Middle Eastern, First Nations, Other',\n"," 'Multiple groups, 140 (61.7%) were white, 83 (36.6%) were African American, and 4 (1.8%) were other race/ethnicity',\n"," 'Multiple groups, White or unknown',\n"," 'Multiple groups, Caucasian; African American',\n"," 'Multiple groups, Brazil',\n"," 'Multiple groups, Black, White or \"Other\" patients',\n"," 'Multiple groups, Mainly Caucasian and Asian',\n"," 'Multiple groups, Asian',\n"," 'Multiple groups, Brazil.',\n"," 'Multiple groups, European-Americans: 871; African-Americans: 191; Hispanics: 75.',\n"," 'Multiple groups, \"Predominantly Caucasian\" cohort',\n"," 'Multiple groups, 664 participants were Caucasian, one was Asian, two were African and the ethnicity of the remaining nine participants is unknown.',\n"," 'Multiple groups, 92% White, 6% African, 2% Asian; French',\n"," 'Multiple groups, 75 (71%) Caucasians, 14 (13%) Hispanics, 11 (10%) Asians, and six (6%) African-American study participants.; Age, ethnicity, and sex were not associated with patient survival.',\n"," 'Multiple groups, North American (treated in Boston).  The 25 were a subset of the study cohort of 61(38 White,5 Hispanic,5 Asian,12 African American).',\n"," 'Multiple groups, Finnish, African American and Native American populations',\n"," 'Multiple groups, Controls- 92.3 % White; Stroke- 94.0 % White.',\n"," 'Multiple groups, Brazilian, 61% non-White',\n"," 'Multiple groups, 88.4% caucasian, 6.6% black, 2.3% hispanic, 2.5% asian, 0.2% other',\n"," 'Multiple groups, White and Other ethnicities',\n"," 'Multiple groups, Asian subset of studies.',\n"," 'Multiple groups, 59 White; 55 African American',\n"," 'Multiple groups, Caucasian, Egyptian',\n"," 'Multiple groups, Netherlands: 62 Caucasian, 1 Asian',\n"," 'Multiple groups, Ethnicity: 93% European, 3% Asian, 1.5% African, 1.5% Latin American, 1% Arab',\n"," 'Multiple groups, 152 sites in 18 countries (Argentina, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Italy, Mexico, Netherlands, Portugal, Russia, Spain, Sweden, Switzerland, United Kingdom, and United States) White N¿=¿1722; Hispanic N¿=¿154; African N¿=¿56; other N¿=¿35',\n"," 'Multiple groups, Caucasian, Egyptian, Mixed',\n"," 'Sub-Saharan African',\n"," 'Multiple groups, 93% Caucasian (n = 191), 2.4% Asian (n = 5), 1.0% African (n = 2), and 3.4% other (n = 3 Hindustani, 3 Surinamese, 1 Israeli). All results remained similar when performed with and without inclusion of non-Caucasian patients.',\n"," 'Multiple groups, one Asian study and one European study',\n"," 'Multiple groups, Tel Aviv, Israel and Las Vegas, and NY,  USA',\n"," 'Multiple groups, 85% White',\n"," 'Multiple groups, predominately New Zealand Caucasian',\n"," 'Multiple groups, Tanzania, Mozambique, South Africa, Uganda, Rwanda, Ethiopia, India, Thailand, Cambodia',\n"," 'Multiple groups, White 97.00%,; Asian 2.30%,; Black 0.40%; other 0.30%',\n"," 'Multiple groups, 82% caucasian',\n"," 'Multiple groups, 98% non-Hispanic or White',\n"," 'Multiple groups, Caucasian, Black, Other',\n"," 'Multiple groups, Non-Hispanic White, Asian, African American and Latino',\n"," 'Multiple groups, Chinese ethnic group (76%), followed by Malays (18%) and Indians (5%)',\n"," 'Multiple groups, Human Variation Panel: 58 EA;53 AA; 60 HCA; unrelated CEPH: 23.  Freq of A: in EA- 0.137; in AA- 0.374; in HCA- 0.068; Lymphoblastoid Cell Lines',\n"," 'Multiple groups, European, African American and East Asian ancestries',\n"," 'Multiple groups, 69% white',\n"," 'Multiple groups, Caucasian, African American, Hispanic, Asian/Pacific Islander, American Indian',\n"," 'Multiple groups, White, Black, Asian, Other',\n"," 'Multiple groups, 171 White; 45 African American',\n"," 'Multiple groups, Fourteen subjects were white and one of Hispanic origin.',\n"," 'Multiple groups, European Australian and African American participants',\n"," 'Multiple groups, 95.6% Caucasian',\n"," 'Multiple groups, 91 Malays;96 Chinese;46 Indians.',\n"," 'Multiple groups, England',\n"," 'Multiple groups, Mixed, Caucasian, Egyptian',\n"," 'Multiple groups, 81% Caucasian',\n"," 'Multiple groups, Israeli, 62 Jewish subjects and 10 subjects that are either Caucasians or Arabs. For simplicity, the Jewish subjects are divided into two main groups: Ashkenazi and ¿non-Ashkenazi¿. The ¿non-Ashkenazi¿ group includes Moroccan, Yemenite, Iraqi, Turkish, Iranian, Libyan, Syrian, Greek subjects and subjects with mixed origin or unknown origin. Five subjects are Jewish of mixed or unknown origin.',\n"," 'Custom, Lymphoblastoid Cell Lines',\n"," 'Multiple groups, Chinese and Indian self-reported ethnicities.',\n"," 'Multiple groups, 24 Black patients, 1 White patient.',\n"," 'Multiple groups, White and Black',\n"," 'Multiple groups, 95 European',\n"," 'Multiple groups, African American, Asian, Hispanic, WHite',\n"," 'Multiple groups, 389 Caucasian; 22 African American; 43 \"Other\".; STRENGTH study.',\n"," 'Multiple groups, US Caucasians and Israeli Jewish cases with US Caucasian controls.',\n"," 'Multiple groups, \"Study populations included Caucasian, east Asian and African.\"',\n"," 'Multiple groups, 35 Caucasian, five African- American, and one Hispanic subjects',\n"," 'Multiple groups, Caucasian and African American ancestries',\n"," 'Multiple groups, White (n=21), Black (n=3), Asian (n=3), Indian (n=3)',\n"," 'Multiple groups, Japanese, other Asian or \"other\"',\n"," 'Multiple groups, Brazilian',\n"," 'Multiple groups, An original 111 patients self-reported as Caucasian 79;African-American 27 and Other 5.',\n"," 'Multiple groups, Responders: White 95 (89%) Black African 1 (1) Indian 5 (5) Chinese 1 (1) Asian other 3 (3) Egyptian 1 (1);Nonresponders: White 75 (89%) Black Caribbean 1 (1) Black African 1 (1) Indian 1 (1) Asian other 5 (6) Egyptian 1 (1).  The frequency of e4 carriers was higher in the nonresponder group, but this was not significant.  When just the white patients were compared, the results were the same.',\n"," 'Multiple groups, mostly Caucasian',\n"," 'Multiple groups, The three ethnic/racial groups with the largest number of genotyped patients were blacks (n = 211, 50.6%), whites (n = 143, 34.3%) and Asians (n = 39, 9.4%). Additional ethnic/racial groups that included American Indians, Native Alaskans, Native Hawaiians, Pacific Islanders or others, contained only 24 (5.7%) genotyped patients',\n"," 'Multiple groups, USA Vandebilt, White or Black, \"Subjects reported their ethnicity and that of their parents and grandparents using check-boxes to choose among “Caucasian”, “African-American”, “Hispanic”, “Chinese”, “Japanese”, and “other” (the latter to be specified). Multiple choices were permitted. A subject was assigned to an ethnic group when both parents and at least 3 out of 4 grandparents were of the same ethnicity.\"',\n"," 'Multiple groups, Studies in paper were from USA (4), China (4), Germany (1), Australia (1), Korea (1), Canada (1)',\n"," 'Custom, Not applicable - mice.; Not applicable.',\n"," 'Multiple groups, Majority Caucasian patients.',\n"," 'Multiple groups, 81.6% Caucasian, 18.4% African-America',\n"," 'Multiple groups, Caucasian (n=188); African-American (n=68)',\n"," 'Multiple groups, Caucasian, African American, Asian and Hispanic participants.',\n"," 'Multiple groups, For all genotypes, there were 7907 subjects.  5749 were \"*1/*1\";78 were *2/*2 (the rest were other genotypes). 12 studies were performed in Asia,13 in the Americas and 14 in Europe.',\n"," 'Multiple groups, \"Most of the adolescents were of Dutch origin\"',\n"," 'Custom, Non human cell line',\n"," 'Multiple groups, black, white, Hispanic mainland US and P.R',\n"," 'Multiple groups, Most subjects were Caucasian college students in their early 20s',\n"," 'Multiple groups, Caucasian, Native American/Alaska Native and Asian participants.',\n"," 'Multiple groups, 86% Caucasian',\n"," 'Multiple groups, South African',\n"," 'Multiple groups, African american and european american',\n"," 'Multiple groups, mostly Asian and White',\n"," 'Multiple groups, PEAR race/ethnicity was self-described by study patient and confirmed by principal components analysis, any patient that did not report black ancestry during screening was considered non-black in statistical analyses.',\n"," 'Multiple groups, 45 infants were white and 5 were of Tunisian or Moroccan descent.',\n"," \"Multiple groups, European American, African American and 'Other' ethnicities.\",\n"," 'Multiple groups, 89% Caucasian; 8% Asian; 3% African-American, age range 30-63, female',\n"," 'Multiple groups, Black or White',\n"," 'Multiple groups, Mainly Caucasian (Italy)',\n"," 'Multiple groups, East and Central/South Asian',\n"," 'Multiple groups, White , African Americans and other from Baltimore , MD.',\n"," 'Multiple groups, Icelandic cases',\n"," \"Multiple groups, Caucasian, African American and 'other'\",\n"," 'Multiple groups, Majority White patients.',\n"," 'Multiple groups, Mostly White.  14/16 receiving tacrolimus once daily were white.  12/15 receiving tacrolimus twice daily were white.',\n"," 'Multiple groups, White, African American',\n"," 'Multiple groups, Caucasian (primarily), and African-American',\n"," 'Multiple groups, Asian and Caucasian subjects',\n"," 'Multiple groups, 89.4% White, 7.7% Black, 3.0% other.',\n"," 'Multiple groups, Chinese; Malay; Indian',\n"," 'Multiple groups, Caucasian, African American, Hispanic or Other ethnicities',\n"," 'Multiple groups, 98% Caucasian.',\n"," 'Multiple groups, 29 White, 10 African American,and 1; \\'Hispanic\"',\n"," 'Multiple groups, 20,786 individuals from several European countries.',\n"," 'Multiple groups, Most studies were in Chinese patients but 5 were not (2 Japanese, 1 Korean, 1 Indian, 1 Turkish) and one was in a non-specific \"Asian\" population',\n"," 'Multiple groups, Caucasian, African American, Hispanic',\n"," 'Multiple groups, 76 Asian;251 Black;405 Hispanic;1687 White; 116 Other (Self-reported).',\n"," 'European, African American/Afro-Caribbean',\n"," 'Multiple groups, predominantly (95%) White European',\n"," 'Multiple groups, Caucasian, Asian, Latino',\n"," 'Multiple groups, Most participants are of Chinese, Malay and Indian origin, however the ethnicity of 11 participants (6 cases and 5 controls) is not given.',\n"," \"Multiple groups, Children's Oncology Group (COG) study (ALTE03N1; Key Adverse Events After Childhood Cancer; clinicaltrials.gov identifier NCT00082745), NCT00082745; principal investigator, Smita Bhatia).\",\n"," 'Multiple groups, Caucasian and Asian studies.',\n"," 'Multiple groups, 291 unrelated non-Hispanic African American adults (150 women and 141 men) from Atlanta, GA, and 294 unrelated non-Hispanic white adults (126 women and 168 men) from Rochester, MN',\n"," 'Multiple groups, 7 non-Hispanic white, 3 Asian, and 2 native Hawaiian/other Pacific Islander',\n"," 'Multiple groups, Netherlands; 93.2% Caucasian (n = 191), 2.4% Asian (n = 5), 1.0% African (n = 2) and 3.4% Other (Hindustani [n = 3], Surinamese [n = 3] and Israeli [n = 1]). Authors stated \"All results remained similar when performed with and without inclusion of non-Caucasian patients (data not shown).\"',\n"," 'Multiple groups, Approximately 95% White',\n"," 'Multiple groups, Netherlands, 97.8% Caucasian',\n"," 'Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander',\n"," 'Multiple groups, European-Americans and African-Americans',\n"," 'Multiple groups, Japanese, European, Korean, Canadian',\n"," 'Multiple groups, Caucasian, White',\n"," 'Multiple groups, Individuals with European and Latin American ancestry',\n"," 'Multiple groups, Dutch SUTOX consortium (five medical centres in the Netherlands), Spanish Oncology Genitourinary Group (SOGUG) medical centres (15 Spanish participating hospitals), and the Cleveland Clinic Foundation (CCF) Taussig Cancer Institute in the United States, overall 96% white',\n"," 'Multiple groups, 85% Black/African American',\n"," 'Multiple groups, mostly whites',\n"," 'Multiple groups, Brazil \"White, Asian, Black, Brown\"',\n"," 'Multiple groups, Trial was carried out at 1113 study locations globally including sites in North America, South America, Europe, and Asia (NCT00412984)',\n"," 'Multiple groups, The majority of donors were Asian, the majority of recipients were Caucasian.',\n"," 'Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European.',\n"," 'Multiple groups, >95% Nordic Caucasian',\n"," 'Multiple groups, Caucasian and African-American children.',\n"," 'Multiple groups, 41% Hispanic, 35% White, and 24% Asian',\n"," 'Multiple groups, Patients of European or African American ancestry',\n"," 'Multiple groups, No other associations between CYP2B6 or ABCB1 genotype and any other treatment response end points were observed overall and among white, black, or Hispanic participants analyzed separately',\n"," 'Multiple groups, Australia. Authors state \"Ethnic proportions were similar in both groups\" but do not define what ethnic groups.',\n"," 'Multiple groups, \"27-center randomized clinical trial in the U.S.: 56% white, 20% African American, 17% Hispanic, 4% Asian/Pacific Islander, 3% American Indian\"',\n"," 'Multiple groups, Participants reported race/ethnicities of Caucasian, African American, Hispanic, Asian or Other',\n"," 'Multiple groups, Australian or European, ethnicity not specified',\n"," 'Multiple groups, South-East Asian and Caucasian. Australian.',\n"," 'Multiple groups, Caucasian and African-American',\n"," 'Multiple groups, Atlanta: black, non-Hispanic white',\n"," 'Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)',\n"," 'Multiple groups, Malaysian, Chinese, Korean, Thai, Indian, Japanese',\n"," 'Multiple groups, Cincinnati Children’s  Hospital  Medical  Center. Cohort was 69.8% boys, 89.1% White, and 87.6% had a diagnosis of CD with a mean age of 16.0 (± 3.8) years',\n"," \"Multiple groups, White,Black,Asian,American Indian children treated at St Jude's Hospital.  p listed as 0.0029- correction not discussed\",\n"," 'Multiple groups, 75% were Caucasian.',\n"," 'Multiple groups, Of the 1536 study participants,; 1362 (88.7%) were selfidentified; as white, with 100 (6.5%) selfidentified; as black, 44 (2.9%) as; Hispanic, 19 (1.2%) as Asian, and 11; (0.7%) as other.',\n"," 'Multiple groups, 77 white, 1 black',\n"," 'Multiple groups, Japanese and Italian',\n"," 'Multiple groups, 75% Caucasian, 17% Black, 3% Asian, 1% mixed race, 3% other.',\n"," 'Multiple groups, USA: non-Hispanic White from Minnesota, non-Hispanic Black from Atlanta',\n"," 'Multiple groups, Self-reported African American, Hispanic and Caucasian ethnicities.',\n"," 'Multiple groups, Dutch: \"Caucasian\":60;\"Negroid\":9,\"Asiatic\":3.',\n"," 'Multiple groups, 43 white, 3 african american, 1 asian',\n"," 'Multiple groups, Mostly Asian',\n"," 'Multiple groups, One Portuguese, one Israeli',\n"," 'Custom, Wuhan University',\n"," 'Multiple groups, European, Amerindian and African ancetry',\n"," 'Multiple groups, 80% white and 18%; black',\n"," 'Multiple groups, mostly White; 10 French centers;Cases:96.0% \"European(White)\";4.1% Asian.  Controls:96.3% \"European(White)\"; 0.8% Black; 2.9% Asian.',\n"," 'Multiple groups, Michigan. \"Most patients were Caucasian (92.3%)\"',\n"," 'Multiple groups, Not stated: studies in Denmark, Czech, China and Greece.',\n"," 'Multiple groups, 79% White; patients from 2 Kansas City hospitals',\n"," 'Multiple groups, Volunteers of European or Latino ethnicity.',\n"," 'Multiple groups, acitretin responders (106) and acitretin nonresponders (84). Responders: White 95; Black African 1; Indian 5; Chinese 1 ; Asian other 3; Egyptian 1 ; Non-responders White 75; Black Caribbean 1; Black African 1; Indian 1; Asian other 5; Egyptian 1 .',\n"," 'Multiple groups, White, non-Hispanic, Black and Middle-Eastern particicpants',\n"," 'Multiple groups, \"The sample consisted predominantly of Caucasian participants (n=40); others reported Asian (n=6), East Indian (n=4), African (n=2), Native (n=1), mixed (n=2), or “other” (n=5) racial backgrounds. One participant endorsed Hispanic ethnicity without indicating race.\"',\n"," 'Multiple groups, Chinese 28; Malays 3; Indian 1',\n"," 'Multiple groups, Caucasian (n=94), Asian (n=2)',\n"," 'Multiple groups, Mixed Asian',\n"," 'Multiple groups, 139 Caucasian, 2 Black African',\n"," 'Multiple groups, Participants were of Hispanic, African American, Caucasian and other ethnicities',\n"," 'Multiple groups, For all genotypes, there were 7907 subjects.  5749 were \"*1/*1\";759 were *1/*3 (the rest were other genotypes). 12 studies were performed in Asia,13 in the Americas and 14 in Europe.',\n"," 'Multiple groups, 43 subjects (81%) were Chinese and 10 (19%) were Malay.',\n"," 'Multiple groups, 78% Caucasian',\n"," 'Multiple groups, White, Black, Asian, Unknown',\n"," 'Multiple groups, 60.8% European American, 18.6% African-American, 17.7% Asian-American, 2.9% Other',\n"," 'Multiple groups, mostly white.',\n"," 'Multiple groups, Centre for Addictions and Mental Health (CAMH) in the Greater Toronto Area, 21–70 years age range, 78% white and 22% non-white, although one participant’s ethnicity is unknown',\n"," 'Multiple groups, Of cases, 87.2% were Caucasian, 8.5% African American, 4.3% other/unknown',\n"," 'Multiple groups, Caucasians, African Americans, Asian/other/unknown',\n"," 'Multiple groups, 38 white, 4 black, 2 asian',\n"," 'Multiple groups, European and African ancestries',\n"," 'Multiple groups, White and Japanese',\n"," 'Multiple groups, 81% White, 11% Asian',\n"," 'Multiple groups, white, black, hispanic',\n"," 'Near Eastern',\n"," 'Multiple groups, predominantly Caucasian population',\n"," 'Multiple groups, STRIDE cohort. Sub-saharan african black and south american hispanic',\n"," 'Multiple groups, White, Hispanic, Black, Asian, Other',\n"," 'Multiple groups, Participants were of Hispanic, Caucasian or African American ethnicity.',\n"," 'Multiple groups, U.S. patients: 20 African American and 44 White',\n"," 'Multiple groups, 81.8% European origin, 5.3% African, 12.9% Asian (in Brazil)',\n"," 'Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients.',\n"," 'Multiple groups, Mostly Caucasian, some Black, Asian, Other',\n"," 'Multiple groups, 68% Caucasian, 32% African American',\n"," 'Multiple groups, Asian, Black, Other and White ethnicities',\n"," 'Multiple groups, Studies from China, Germany, Egypt',\n"," 'Multiple groups, Netherlands',\n"," 'Multiple groups, White, Latino, African American, Asian',\n"," 'Multiple groups, 93% white',\n"," 'Multiple groups, Caucasian (n=27), Asian (n=3), East Indian (n=3), Black (n=2), Native North American (n=1), mixed race (n=4)',\n"," 'Multiple groups, 24 Whites, four African-; Americans,and two Asians',\n"," 'Multiple groups, Caucasian, Asian, Latino and African American participants.',\n"," 'Multiple groups, \"36 Caucasians, 42 Latin-Americans and 2 Blacks\"',\n"," 'Multiple groups, France',\n"," 'Multiple groups, Study cohort was primarily of European ancestry.',\n"," 'Multiple groups, Germany, Austria, Switzerland, France, Italy',\n"," 'Latino',\n"," 'Multiple groups, European, UK, Japan, Canada',\n"," 'Custom, HIV-negative males or non-pregnant and non-lactating females, aged between 18 and 60\\u2009years',\n"," 'Multiple groups, White and Non-White patients',\n"," 'Multiple groups, Participants from studies carried out in USA, Germany, Spain, China, India, Japan and Korea.',\n"," 'Multiple groups, USA and Canada: 74% Caucasian, 26% African American',\n"," 'Multiple groups, Chinese (n=67) and Indian (n=87)',\n"," 'Multiple groups, 60.3% Euro-Brazilians; 39.7% Afro-Brazilians',\n"," 'Custom, Not applicable - study was carried out using rectal organoids',\n"," 'Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicities. 13 participants did not give an ethnicity.',\n"," 'Multiple groups, Caucasian, Mediterranean, Asian, Black, Other',\n"," 'Multiple groups, Black, Hispanic, and White',\n"," 'Multiple groups, \"Study subjects were predominantly Black men\"',\n"," 'Multiple groups, South African: Mixed Ancestry, indigenous Africans (Black), those of European ancestry(White) and descendents from Indian and South-east Asian immigrants (Other).',\n"," 'Multiple groups, Malay, Indian, Chinese',\n"," 'Multiple groups, \"Ethnicity was not explicitly recorded, but the mast majority (>95%) of patients were Caucasian\"',\n"," 'Multiple groups, Portugal, 44 \"Caucasian\" 1 \"African\"',\n"," 'Multiple groups, Majority of participants were non-Hispanic Whites.',\n"," 'Multiple groups, 23 White and 1 African',\n"," 'Multiple groups, Mainly Caucasian (93.3%)',\n"," 'Multiple groups, Finnish',\n"," 'Multiple groups, Malay (n=16), Chinese (n=9), Indian (n=1)',\n"," 'Multiple groups, Discovery cohort - meta-analysis of European Americans and African Americans from the COGA study',\n"," 'Multiple groups, 92% Caucasian',\n"," 'Multiple groups, 94 patients; were of white Spanish origin, one was of African (Moroccan) origin, and one was of Asian (Indian) origin',\n"," 'Multiple groups, Studies include Asian, Caucasian, African-American, Hispanic and Polynesian participants and participants of unreported ethnicity.',\n"," 'Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European patients.',\n"," 'Multiple groups, USA, Caucasians (n = 114) and African American (n = 26)',\n"," 'Multiple groups, predominantly white (98%)',\n"," 'Multiple groups, White (32) and African-American (3)',\n"," 'Multiple groups, Chinese (n=36), Malay (n=8) and Other (n=1)',\n"," 'Multiple groups, The majority of patients were from Central Europe, with 9 patients from Turkey and one patient each from the Ukraine, Syria, Tunisia, Dubai and Asia',\n"," 'Multiple groups, 93% White',\n"," 'Multiple groups, 95% Caucasian (Italy)',\n"," 'Multiple groups, 1366 individuals  from 402 African American familes and 671 individuals from 200 European American families.    People were mostly from U.S. mid-south.  The study  included as many biological parents and siblings of probands as was possible, regardless of smoking status.',\n"," 'Multiple groups, African and Caucasian',\n"," 'Multiple groups, Africans and individuals of African descent',\n"," 'Multiple groups, 73 (93.6%) Caucasian race',\n"," 'Multiple groups, Maori, Pacific Islanders and Caucasians',\n"," 'Multiple groups, Maori and Pacific Islander, and Caucasian',\n"," 'Multiple groups, 1560 EA and 363 AA kidney allograft recipients',\n"," 'Multiple groups, French and UK',\n"," 'Multiple groups, Netherlands: recipients were 79% white, 10% Asian, 9% Black, 2% other. Races of donors not specified.',\n"," 'Custom, meta-analysis',\n"," 'Multiple groups, 84.4% Caucasian;9.8% African ancestry;2.9% Asian;2.9% other.',\n"," 'Unknown',\n"," 'Multiple groups, South Africa : 9 white, 21 black, 1 indian individuals',\n"," 'Multiple groups, \"Volunteers mainly self-reported as Caucasian (n = 83) whereas 34 self-reported as Latino-Americans and 1 as Black, who was merged with the Latino-American volunteers in a group called “Mixed” ethnicity. \"',\n"," 'Multiple groups, 82% White.',\n"," 'Multiple groups, 82.4% white',\n"," 'Multiple groups, 72% White;27% Black; 2% Other',\n"," 'Multiple groups, USA \"90% Caucasian, 8.4% African American, 1.6% Other\"',\n"," 'Multiple groups, 701 patients from Malaysia (Malay, Chinese or Indian), 803 patients from Hong Kong (Han Chinese).',\n"," 'Multiple groups, 88.9% European, 9.4% African American, 1.4% Asian, 0.3% admixed',\n"," 'Multiple groups, Caucasian, Black/African American, Asian, Other',\n"," 'Multiple groups, 94% \"Caucasian\"; 6% \"Chinese or Asian\"',\n"," 'Multiple groups, Finnish (mostly Caucasian)',\n"," 'Multiple groups, 140 Whites,83 African Americans, 4 \"other\" from Baltimore, Maryland',\n"," 'Multiple groups, Mostly East Asian',\n"," 'Multiple groups, 90% Caucasian',\n"," 'Multiple groups, Singapore: Chinese, Malay, Indian',\n"," 'Multiple groups, Majority of patients were of European ancestry',\n"," 'Multiple groups, 552 Caucasian; 106 African American',\n"," 'Multiple groups, 29 White, 1 African',\n"," 'Multiple groups, 79% were White.  Patients from 2 Kansas city hospitals.',\n"," 'Multiple groups, Chinese, Indian, Malaysian',\n"," 'Multiple groups, Vanderbilt USA: 89.2% White, 9.8% Black, 1% Hispanic',\n"," 'Multiple groups, 85% Caucasian',\n"," 'Multiple groups, Brazil, 73% White other ethnicities not described',\n"," 'Multiple groups, South African, Peruvians, American.',\n"," 'Multiple groups, German, Austrian, Swiss, French, Italian',\n"," 'Multiple groups, Canada; >60% Western European Origin',\n"," 'Multiple groups, Patients with European, American, African or Asian ancestry.',\n"," 'Multiple groups, Self-reported: 143 White, 37 Black, 1 Asian, 8 other.',\n"," 'Multiple groups, Predominantly Caucasian and Asian',\n"," 'Multiple groups, Participants were identified as Caucasian, Turkish or being of European ancestry',\n"," 'Multiple groups, European and/or Middle-Eastern ancestry',\n"," 'Multiple groups, white, black',\n"," 'Multiple groups, Caucasian, Asian, African, Hispanic',\n"," 'Multiple groups, mostly White (81%)',\n"," 'Multiple groups, Mainly Japanese',\n"," 'Multiple groups, studies were from Japan, Korea or China one from Singapore - this is why did not check East Asian',\n"," 'Multiple groups, Non-Hispanic whites, Asians, African Americans and Latinos',\n"," 'Multiple groups, In total, there were 556 individuals of African descent (Africans,; African Americans, and black Brazilians), 1,889 Asians, and; 6,908 Caucasian/white Americans.',\n"," 'Multiple groups, Canadian patients with European ancestry; (n=263) and non-Europeans (n = 81),',\n"," 'Multiple groups, \"White and black or African American\" subjects',\n"," 'Multiple groups, SIngapore: Chinese, Malay, Indian',\n"," 'Multiple groups, USA, Vanderbilt: Black, White, Hispanic',\n"," 'Multiple groups, Brazilian population',\n"," 'Multiple groups, Austalian',\n"," 'Multiple groups, Mostly Caucasian, ranging from 88% white to >95% white cases',\n"," 'Multiple groups, Maori, Pacific Islander and Caucasian',\n"," 'Multiple groups, Chinese, Indian and Malay from Singapore',\n"," 'Multiple groups, 87.5% were Caucasian',\n"," 'Multiple groups, White and Black (n=2)',\n"," 'Multiple groups, White/European American; Black/African American; other',\n"," 'Multiple groups, 82% White',\n"," 'Multiple groups, 84% European',\n"," 'Multiple groups, German, Austrian, Switzerland, France, Italy',\n"," 'Multiple groups, USE; 80% Caucasian, 12% African American, 6% Hispanic, 2% Asian',\n"," 'Multiple groups, Eighty-one normal breast (4 European American (CA), 8 African American (AA) and 69 of unknown ethnicity; 78 female, 2 male and 1 unknown gender)',\n"," 'Multiple groups, Trinidad, self reported African descent and Indian descent with at least three grandparents of the same ethnic group.',\n"," 'Multiple groups, Asian, Black, Caucasian, Other',\n"," 'Multiple groups, Caucasian, African-American, Other',\n"," 'Multiple groups, Netherlands, Italy, Turkey, Denmark, Sweden, Finland',\n"," 'Multiple groups, Caucasian n=44, African-American n=13, Hispanic n=30, Asian n=6, Other n=2.',\n"," 'Multiple groups, Jewish. Israel, 24% were Ashkenazi',\n"," 'Multiple groups, 93% Caucasian 7% Indian or unknown',\n"," \"Multiple groups, Patients reported race of 'White', 'Black or African American' or 'Other' and ethnicity of 'Non-Hispanic or Latino' or 'Hispanic or Latino'\",\n"," 'Multiple groups, 3 Chinese; 6 European',\n"," 'Multiple groups, 79% white',\n"," 'Multiple groups, 92% White, 8% Black',\n"," 'Multiple groups, Caucasians and african americans',\n"," 'Multiple groups, African, Asian, Mexican.  Patients were enrolled in UCSF study protocols 9203 or 9303.',\n"," 'Multiple groups, Canadian.',\n"," 'Multiple groups, \"Ethnicity (% white) 69.1 % of PE responsive 66.2% of PE non-responsive\"',\n"," 'Multiple groups, White, Japanese, Korean, Iranian, Chinese',\n"," 'Multiple groups, Caucasian and Asian',\n"," 'Multiple groups, \"both parents of 79% of the cases and 84% of the controls born in Sweden.\"',\n"," 'Multiple groups, White, African American, Asian',\n"," 'Multiple groups, 72% of patients were Caucasian; 27% were African American and 1% were Asian.',\n"," 'Multiple groups, 93% Caucasian',\n"," 'Multiple groups, mostly Caucasians',\n"," 'Multiple groups, 94 White; 49 African American',\n"," 'Multiple groups, USA',\n"," 'Multiple groups, Jewish.  Israel, 24% Ashkenazi',\n"," 'Multiple groups, Mainly Caucasian',\n"," 'Multiple groups, Patients from Sao Palo and Maringa, Brazil.',\n"," 'Multiple groups, European, Han Chinese, Korean, Thai, Japanese, Malaysian',\n"," 'Multiple groups, Majority Caucasian, several Native Americans, one patient race not specified.',\n"," 'Multiple groups, White, African-American, Hispanic, Other',\n"," 'Multiple groups, Brazilian mixed',\n"," 'Multiple groups, Asian subjects - includes studies from China, Malaysia and Iran',\n"," 'Multiple groups, 29 white, 1 African',\n"," 'Multiple groups, 95% White',\n"," 'Multiple groups, Caucasian and Unknown',\n"," 'Multiple groups, European (Spanish and Italian, especially),; Amerindian and a small group of Middle Eastern  origin',\n"," 'Multiple groups, Caucasian and African American participants',\n"," 'Multiple groups, Caucasian (n=60), African (n=11), Asian (n=3), American Indian (n=2)',\n"," 'Multiple groups, USA - 88.5% Caucasian, 7% African American, 2.6% Hispanic, 1.9% other.',\n"," 'Multiple groups, Caucasian 76; African-American 4; Hispanic origin 29; Asian origin 11.  38 women.  Avg age 65.5 +/- 10.9 .  Patients were at Baylor College of Medicine, Houston,; TX, United States.  Patients were scheduled for elective; percutaneous coronary intervention (PCI). All; patients had received aspirin 81¿325mg daily for; z1week before the PCI and had not received a; thienopyridine or GP IIb/IIIa inhibitor in the week; prior to enrollment',\n"," 'Multiple groups, Britain 90% White, 4% Asian/Indian/Pakistani, 6% mixed background',\n"," 'Multiple groups, 49 women and 160 men, the majority of whom were white (95%)',\n"," 'Multiple groups, Controls- 92.3 % White; Cases- 90.9% White.',\n"," 'Multiple groups, The majority; of the population was white (European American), and 20 of; the patients were black (African American).',\n"," 'Multiple groups, 59 White;  50 African American',\n"," 'Multiple groups, Self-identified as Black, White or Hispanic.',\n"," 'Multiple groups, St Judes',\n"," 'Multiple groups, Caucasian, Latin-American, Black and Arab subjects',\n"," 'Multiple groups, 17 Caucasians, 2 Hispanics, 1 Asian',\n"," 'Multiple groups, White and Hispanic participants',\n"," 'Multiple groups, 74% White',\n"," 'Multiple groups, Chinese, Malays, Indian',\n"," 'Multiple groups, United States',\n"," 'Multiple groups, USA: majority African Americans (97%), 3 Hispanic subjects, 1 Caucasian.',\n"," 'Multiple groups, White European and Black African',\n"," 'Multiple groups, Asians (n = 1103), blacks (n = 670), and whites (n = 3113)',\n"," 'Multiple groups, 95% Caucasian',\n"," 'Multiple groups, White,African,Asian,Mexican.',\n"," 'Multiple groups, European and Non-European',\n"," 'Multiple groups, >95% were Caucasian patients.',\n"," 'Multiple groups, Brazil, 78-87% Caucasian',\n"," 'Multiple groups, Mixed Asian (Hong Kong)',\n"," 'Multiple groups, 94% white',\n"," 'Multiple groups, Asian and Caucasian individuals.',\n"," 'Multiple groups, Cohort was \"90% Caucasian\", all DPYD variant carriers were \"Caucasian\"',\n"," 'Multiple groups, African American, Caucasian.',\n"," 'Multiple groups, 90.7% European, 6.4% African, 2.2% Asian, 0.6% Native American.  Ethnicity: 8.4% Hispanic.  Mayo clinic,M.D. Anderson Cancer Center, Memorial Sloan-Kettering Cancer Center.',\n"," 'Multiple groups, non-Hispanic White, non-Hispanic Black, Hispanic White, Hispanic Black, Other',\n"," 'Multiple groups, predominantly Caucasian (n = 80), with six of African; descent, two Asian and one Mongolian¿Caucasian',\n"," 'Multiple groups, White and South Asian',\n"," 'Multiple groups, 89% White, 11% Nonwhite; Fred Hutchinson Cancer Research Center, USA',\n"," 'Multiple groups, \"All included cases were pure Filipinos except for five patients (one case and four controls) who were considered as; mixed Filipinos. Those patients who were considered as mixed Filipinos had Chinese, German, Indian and Spanish; descent\" \"Mixed Filipino = at least one grandparent came from other race.\"\"Tagalog is the ethnolinguistic; group with the highest population in the Philippines. In this study, majority of the recruited patients belong; to this ethnolinguistic group suggesting that the study population is culturally almost homogenous. However,; the study population may not be representative of the Filipino population\"',\n"," 'Multiple groups, African = 24, Caucasian = 27, Maghrebi = 2',\n"," 'Multiple groups, 79% Caucasian',\n"," 'Multiple groups, Microsome derived from Caucasian, African American and Hispanic donors.',\n"," 'Multiple groups, Caucasian (85%), African-descent (10%), Asian-descent (5%)',\n"," 'Multiple groups, 87% White',\n"," 'Multiple groups, Caucasian, Mediterranean, Asian, Black',\n"," 'Multiple groups, White, African-American, Other',\n"," 'Multiple groups, 11% Black, 47% Hispanic, 41% White',\n"," 'Multiple groups, French study: Caucasian, Black and Other',\n"," 'Multiple groups, Study was carried out in the Netherlands so authors expect \"that virtually all participants are Caucasians\". However, this is not confirmed.',\n"," 'Multiple groups, United Kingdom- Leeds',\n"," 'Multiple groups, African-American (n=37), European-American (n=46), Asian (n=5), Unknown (n=1).',\n"," 'Multiple groups, Japanese and Caucasians',\n"," 'Multiple groups, 97.3% of participants were of \"Dutch origin\".',\n"," 'Multiple groups, Black n=23, White n=119, Middle Eastern n=12, South Asian n=26',\n"," 'Multiple groups, 74 Caucasian, 1 African American',\n"," 'Multiple groups, White and African-American',\n"," 'Multiple groups, Thai, White, Black, North-East Asians',\n"," 'Multiple groups, Brazil: About 86% of the patients are of European ancestry and 14% are of African ancestry',\n"," 'Multiple groups, Atlanta: black and non-Hispanic white',\n"," 'Multiple groups, Singapore: 131 Chinese, 81 Malays and 36 Asian Indians',\n"," 'Multiple groups, European, UK, Japan',\n"," 'Multiple groups, Patients reporting Chinese, Malay or Indian ethnicity.',\n"," 'Multiple groups, Multi-ethnic Asian patients from Singapore includes Chineses, Malays and Indians.',\n"," 'Multiple groups, African American/African American/Hispanic Asian/White/Hispanic White/Non-Hispanic',\n"," 'Multiple groups, 80% Caucasian',\n"," 'Multiple groups, n=1366 African American, n=671 European American.',\n"," 'Multiple groups, In the full set of all drug hypersensitive patients, 89%(133) were of European ancestry and could be qualified as ¿Caucasians¿. One patient was from North Africa, eight originated from sub-Saharan Africa, six from Asia and two from South America',\n"," 'Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent',\n"," 'Multiple groups, 57 Caucasian, 2 African',\n"," 'Multiple groups, White European and South Indian ancestry',\n"," 'Multiple groups, mostly white males (73.1% were male; 84.8% were white, and the remainder were Hispanic)',\n"," 'Multiple groups, USA \"49 White, 18 Black, 7 Other\"',\n"," 'Multiple groups, Europe, US, UK',\n"," 'Multiple groups, 170 unrelated non-Hispanic men (62 blacks and 108 whites)',\n"," 'Multiple groups, Thirty eight patients (43%); were Caucasians, eight (9%) were Hispanic, 22 (25%); were African, 15 (17%) were South Americans, five; (6%) were Asians and one (1%) was native to the Middle; East.',\n"," 'Multiple groups, White, Black',\n"," 'Multiple groups, Netherlands, Germany, Canada',\n"," 'Multiple groups, Chinese, Malay, Indian',\n"," 'Multiple groups, Caucasian, Black, Hispanic/Latino patients.',\n"," 'Multiple groups, For all genotypes, there were 7907 subjects.  5749 were \"*1/*1\";1216 were *1/*2 (the rest were other genotypes). 12 studies were performed in Asia,13 in the Americas and 14 in Europe.',\n"," \"Multiple groups, Asian, African American, White or 'Other' ethnicities\",\n"," 'Multiple groups, Microsomes derived from Caucasian, African American and Hispanic donors.',\n"," 'Multiple groups, European Caucasian and one of Asian origin',\n"," 'Multiple groups, mainly of European descent (98.6%)',\n"," 'Multiple groups, Black (n=12), White (n=81), South Asian (n=20), Other (n=5)',\n"," 'Multiple groups, UK: 67% \"Caucasian ethnicity\" 33% \"Black ethnicity\"',\n"," 'Multiple groups, 72% White;27% Black; 2% other',\n"," 'Multiple groups, 94% were White (all were patients at Ottawa Hospital Thrombosis Clinic).',\n"," 'Custom, \"Due to the diverse mixed lineage inherent to the Australian population, participants in our study could; not be stratified into traditional distinct homogeneous groups by ethnicity/race.\"',\n"," 'Multiple groups, non-Caucasian.',\n"," 'Multiple groups, 33 Japanese, 27 Caucasian liver samples',\n"," 'Multiple groups, Non hispanic white and black',\n"," 'Multiple groups, Study classified ethnicity as African-American and Non-African American',\n"," 'Multiple groups, European and Asian (Chinese, Korean, Japanese, \"Asia\" unspecified)',\n"," 'Multiple groups, Caucasian and Hispanic/Latino patients',\n"," 'Multiple groups, 86% African-American;14% White.',\n"," 'Multiple groups, Brazilian patients (white, brown or black, according to Brazilian census categories)',\n"," 'Custom, recombinant protein',\n"," 'Multiple groups, USA - 64.6% Caucasian, 14.1% African American, 10.3% Hispanic, 10.9% other',\n"," 'Multiple groups, Israeli - European, Middle Eastern and Asian mixed ancestry',\n"," 'Multiple groups, 80% South African Coloured, 12% Xhosa, 8% European',\n"," 'Multiple groups, All the patients were white, apart from three (one Indian, one Yemeni, one half-Thai). All of these control subjects were white.',\n"," 'Multiple groups, n=1 Arabian patient, the rest were Caucasian.',\n"," 'Multiple groups, USA, Caucasians (n = 114) and Africanâ¿¿American (n = 26)',\n"," 'Multiple groups, Asian, Caucasian, Africa-American',\n"," 'Multiple groups, 46 Whites; 24 Blacks',\n"," 'Multiple groups, South African - Caucasian, Black African, Cape mixed, Indian',\n"," 'Multiple groups, Han Chinese, Indian, Malay in Singapore',\n"," 'Multiple groups, Individuals were included regardless of race or ethnicity',\n"," 'Multiple groups, Japanese Americans, European Americans and Native Hawaiian',\n"," 'African American/Afro-Caribbean',\n"," 'Multiple groups, 62% white',\n"," 'Multiple groups, From Table 2: Race; \\u2002Malay; \\u2002Chinese; \\u2002Indian; \\u2002Iban; \\u2002Bidayuh; \\u2002Melanau; \\u2002Bajau; \\u2002Kadazan; \\u2002Dusun; \\u2002Suluk',\n"," 'Multiple groups, Cases - Mixed, Caucasian and Black; Controls - Afrikaner, Mixed, Caucasian and Black',\n"," 'Multiple groups, Studies from China, Germany,',\n"," 'Multiple groups, Black(25) and White (77) Children',\n"," 'Multiple groups, Maori, other Pacific Islander, and Caucasian',\n"," 'Multiple groups, Asian (n=126) and Caucasian (n=71)',\n"," 'Multiple groups, White,Black,Other',\n"," 'Multiple groups, Brazilian (African Americans and Whites).',\n"," 'Multiple groups, Cases: 124 Non-Hispanic Whites;16 Hispanics;12 Blacks; 18 Other.  Controls: 252 Non-Hispanic Whites;29 Hispanics;14 Blacks;22 Other.',\n"," 'Multiple groups, White, African-American, Hispanic',\n"," 'Multiple groups, predominantly European ancestry (90.2%)',\n"," 'Multiple groups, Healthy volunteers (12 Caucasian, 5 Asian, 1 African American, 1 subject undetermined)',\n"," 'Multiple groups, African Americans and Caucasians',\n"," 'Multiple groups, African American, including self-reported Hispanics.',\n"," 'Multiple groups, 95.3% European American,; 2.1% African American, 1.2% Asian American, 1.2%; Hispanic, and 0.2% mixed-race',\n"," 'Multiple groups, Children of European, Amerindian and African ancestry from the Amazon region.',\n"," 'Multiple groups, Malaysia: Malay, Chinese, Indian, Iban, Bidayuh, Melanau, Bajau, Kadazan, Dusun, Suluk',\n"," 'Multiple groups, Participants were of Caucasian, Indigenous Australian, Torres Strait Islander, Asian, Indian or Turkish ethnicity.',\n"," 'Multiple groups, Caucasian (n=52), African American (n=12) or American Indian or Alaskan native (n=1). One participant did not identify a racial background. Seven participants self identified their ethnicity as Hispanic',\n"," 'Custom, Not applicable - study was carried out in PBE cells',\n"," 'Multiple groups, African American and White',\n"," 'Multiple groups, Caucasian (n=13) and African American (n=1)',\n"," 'Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian',\n"," 'Multiple groups, Asian, American, African, European',\n"," 'Multiple groups, Asian, Caucasian and African subjects',\n"," 'Multiple groups, White, Black and other',\n"," 'Multiple groups, Caucasian, Afro-Caribbean, South Asian, South East Asian',\n"," 'Multiple groups, Australia: 4% were Caucasian, 13% Asian, 10% Pacific Islander, and 13% others',\n"," 'Multiple groups, Patients from Belem, Amazon, Brazil.',\n"," 'Multiple groups, probably White (Spanish mental health center).',\n"," 'Multiple groups, European (n=128), African-American (n=55), Other (n=10)',\n"," 'Multiple groups, Black, Caucasian, Mixed race, Asian, Other',\n"," 'Multiple groups, Mainly Caucasian, 2 Hispanic, 1 African-American and 1 American Indian',\n"," 'Multiple groups, The larger cohort is \"mostly Caucasian\".',\n"," 'Multiple groups, 76% Caucasian, 15-18% African American, 6-9% other/unknown',\n"," 'Multiple groups, USA approx 62% White, 6% Black or African American, 27% Hispanic, 5 % other',\n"," 'Multiple groups, Chinese, Indian, Malay',\n"," 'Custom, functional study in dysgenic myotubes; dysgenic myotubes',\n"," 'Multiple groups, European American, European Australian and African American participants',\n"," 'Multiple groups, not stated for the individuals genotyped, full cohort was a mixed population',\n"," 'Multiple groups, 97% White',\n"," 'Multiple groups, Caucasian and African American',\n"," 'Multiple groups, White British and mixed other',\n"," 'Multiple groups, 96% of participants were Caucasian. Study carried out in Switzerland.',\n"," 'Multiple groups, White, Black, Asian',\n"," 'Multiple groups, Brazil approximately half White half non-white',\n"," 'Multiple groups, White (nevirapine sensitive n=13, tolerant n=239) and Asian (sensitive n=6, tolerant n=23)',\n"," 'Multiple groups,  majority (~93%) of the subjects enrolled in this study were white',\n"," 'Multiple groups, 230 white subjects and 33 nonwhite subjects',\n"," 'Multiple groups, White, Black, Native American, Hispanic',\n"," 'Multiple groups, 94% White',\n"," 'Multiple groups, Self reported - black, white, Asian, and other.; Analysis was also done when subdivided by ancestry genetic markers but was not significantly different.',\n"," 'Multiple groups, \"All subjects were Caucasians with the exception of two Africans\"',\n"," 'Multiple groups, 80% White, remaining unspecified',\n"," 'Multiple groups, 19 Black patients, 1 White patient.',\n"," 'Multiple groups, African-American, Caucasian, Asian-American',\n"," 'Multiple groups, predominantly Caucasian',\n"," 'Multiple groups, 3 high volume centers in the Netherlands (> 85% Caucasian)',\n"," 'Multiple groups, Bolivian and Argentinian subjects',\n"," 'Multiple groups, 63.5% Caucasian; 34.5% African American; 2.0% Other.  patients undergoing non-emergency PCI at the Sinai Hospital of Baltimore (NCT00799396).',\n"," 'Multiple groups, USA, Canada, UK',\n"," 'Multiple groups, African American and European American',\n"," 'Multiple groups, European-Americans, African Americans and \"Others\" recruited in Germany, Ohio (USA) and New York(USA).',\n"," 'Multiple groups, 22 white, 8 black',\n"," 'Multiple groups, non-Hispanic and Hispanic Caucasian',\n"," 'Multiple groups, 38 Whites; 2 Blacks',\n"," 'Multiple groups, Britain: 97% European, 2% South Asian, 1% East Asian',\n"," 'Multiple groups, Non-African-American',\n"," 'Multiple groups, USA : 90% White, 5% African american, 5% other',\n"," 'Multiple groups, Caucasian, Hispanic, African American, American Indian, Asian, Native Hawaiian and \"other\" ethnicities.',\n"," 'Multiple groups, Thirty-one (79%) patients were Caucasian, six (15%) were Asian and two (5%) were Hispanic.',\n"," 'Multiple groups, European Caucasian and African American patients',\n"," 'Multiple groups, White, non-Hispanic; Asian; BlackWhite, Hispanic',\n"," 'Multiple groups, Brazil: \"51% Caucasian,  16% African, 32% Intermediate, 1% other\"',\n"," \"Multiple groups, Caucasian, African, African American, Arabic and 'Other' ethnicities\",\n"," 'Multiple groups, European, African-American, Other',\n"," 'Multiple groups, Majority White',\n"," 'Multiple groups, Brazilian mixed cohort',\n"," 'Multiple groups, Caucasian and Asian patients',\n"," 'Multiple groups, USA, Caucasian and African american',\n"," 'Multiple groups, Cincinnati Children’s Hospital Medical Center, self identified Caucasian and African American',\n"," 'Multiple groups, mostly White (>90%)',\n"," 'Multiple groups, 84% were white',\n"," 'Multiple groups, European-American plus African American',\n"," 'Multiple groups, Caucasian (n=48), African-American (n=4), Hispanics (n=2)',\n"," 'Multiple groups, Majority white British',\n"," 'Multiple groups, Europe, UK, US, Taiwan',\n"," 'Multiple groups, 8 African American, 1 African American/Hispanic, 2 Asian, 7 Caucasian/Hispanic, 26 Caucasian/Non-Hispanic',\n"," 'Multiple groups, This is a retrospective pharmacogenetic analysis of a pooled dataset of selected HCV GT1- or GT4-infected participants enrolled in ten Phase II/III clinical trials of EBR/GZR: C-WORTHY (MSD Protocol, 5172-035; ClinicalTrials. gov identifier NCT01717326), C-SCAPE (5172-047; NCT01932762), C-SALVAGE (5172-048; NCT02105454), C-SURFER (5172-052; NCT02092350), Japan Phase II/III study (5172-058; NCT02203149), C-SALT (5172-059; NCT02115321), C-EDGE Treatment-Naive (5172-060; NCT02105467), C-EDGE CO-INFECTION (5172-061; NCT02105662), C-EDGE CO-STAR (5172-062; NCT02105688), C-EDGE Treatment-Experienced (5172-068; NCT02105701)',\n"," 'Multiple groups, 64.7% White, 32.1% Black, 0.3% American Indian/Alaskan native, 0.9% Asian/Pacific Islander, 2.1% other, 11.5% Hispanic',\n"," 'Multiple groups, USA: non-Hispanic White, Minnesota, non-Hispanic Black, Atlanta',\n"," 'Multiple groups, pediatric',\n"," 'Multiple groups, mostly white',\n"," 'Multiple groups, 64% were Caucasian, 13% Asian, 10% Pacific Islander and 13% others',\n"," 'Multiple groups, USA: White (n=63), African American (n=1), Hispanic (n=45), Asian (n=28)',\n"," 'Multiple groups, 74% Caucasian;16% Hispanic;4% African American;6% other.',\n"," 'Multiple groups, African-American, Caucasian, Chinese and Korean',\n"," 'Multiple groups, White, non-Hispanic; Asian; Black; White, Hispanic',\n"," 'Multiple groups, The majority of study participants were Caucasian',\n"," 'Multiple groups, White, Afican american',\n"," 'Multiple groups, 90% White',\n"," 'Multiple groups, Most of patients were White, but race information was not captured uniformly between the studies.',\n"," 'Multiple groups, White, Hispanic, Asian/Pacific Islander, Other',\n"," 'Multiple groups, Caucasian, African American and biracial/multiracial participants',\n"," 'Multiple groups, 45% Chinese, 22% Malay, 23% Iban, 10% others',\n"," 'Multiple groups, 43 subjects (81%) were Chinese and 10 (19%) were Malay',\n"," 'Multiple groups, Italy, specified 37.5% Caucasian, 62.5% Other.',\n"," 'Multiple groups, 184 sites in the U.S.; Puerto Rico',\n"," 'Multiple groups, Italy',\n"," 'Multiple groups, USA: White, African American, Hispanic',\n"," 'Multiple groups, 8 studies',\n"," 'Multiple groups, Singapore: Chinese (85%), Malay, Indian',\n"," 'Multiple groups, predominantly comprised of patients of European descent (self-identified (Caucasians) (comprising 84.7% of the study cohort), it also included a small number of self-reported Hispanics (13.9% of the cohort).',\n"," 'Multiple groups, Mostly white (91%)',\n"," 'Multiple groups, 225 Caucasians and 146 Blacks, Germany',\n"," 'Multiple groups, mainly Whilte',\n"," 'Multiple groups, European American, African American, Hispanic',\n"," 'Multiple groups, 23 White and 1 Black',\n"," 'Multiple groups, Black, White, Other',\n"," 'Multiple groups, 16 Asian, 69 white, 91 black or African-American patients and 7 patients of other ethnic origins',\n"," 'Multiple groups, South African: 56 individuals were Black, one individual white and one individual \"colored\"',\n"," 'Multiple groups, non-HIspanic Caucasian, African-American, Hispanic Caucasian',\n"," 'Multiple groups, European, UK, US, Japan',\n"," 'Multiple groups, White, Hispanic, Unknown',\n"," 'Multiple groups, 6,127 individuals of European and African descent',\n"," 'Multiple groups, France, the Netherlands, Belgium, United States, Germany, China, India ,Singapore and Malaysia',\n"," 'Multiple groups, Three Whites and One Malaysian from Singapore',\n"," 'Custom, COS-1 cells',\n"," 'Multiple groups, Brazilian. 83.7% European ancestry, 16.3% African ancestry',\n"," 'Multiple groups, 40 White; 5 African-American;3 other.  Patients at Washington University Medical Center, St. Louis, MO, USA',\n"," 'Multiple groups, Canada',\n"," 'Multiple groups, Mostly white',\n"," 'Multiple groups, 98% Caucasian',\n"," 'Multiple groups, Brazil, \"Brazilians are a highly admixed population with Amerindian, European and African ancestral roots\"',\n"," 'Multiple groups, Studies include Asian, Caucasian, Hispanic, Polynesian participants and participants of unreported ethnicity.',\n"," 'Multiple groups, Asian and Caucasian participants',\n"," 'Multiple groups, Majority Caucasian',\n"," 'Multiple groups, Caucasian, Asian, African',\n"," 'Multiple groups, mostly white males (73.1% were male; 84.8% were white, and the remainder were Hispanic',\n"," 'Multiple groups, \"Almost all adolescents (94.1%) lived in households with both parents being Caucasian, the remainder had a least one non-Caucasian parent\"',\n"," 'Multiple groups, USA - 66.7% Caucasian, 18.8% African American, 7.4% Hispanic, 7.1% other',\n"," 'Multiple groups, White and hispanic (36%), white and non-hispanic (57%)',\n"," 'Multiple groups, White, Black, Hispanic',\n"," 'Multiple groups, 92% white',\n"," 'Multiple groups, All patients were from Russian hospitals.  Racial breakdown is given for the group of all pediatric cancer patients (a superset of the ALL patients).  White: 413;Asian:6;Ural:3;Other:21.',\n"," 'Multiple groups, White, Black, HIspanic, Asian and Other ethnicities.',\n"," 'Multiple groups, 41% African American; 28% Caucasian (European); 18% Hispanic; 5% Asian; 8% other',\n"," 'Multiple groups, patients at Washington University Medical Center.  79 White;13 African-American.',\n"," 'Multiple groups, 99 Chinese, 12 Malaysian, 13 Indians',\n"," 'Multiple groups, Asian subjects (encompassing Japanese, non-Japanese Asian and Indian Asian subjects)',\n"," 'Multiple groups, European Americans and African Americans in San Antonio, Texas.',\n"," 'Multiple groups, Native American (n=20) and Caucasian (n=11)',\n"," 'Multiple groups, UK, Spain, Italy',\n"," 'Multiple groups, Black,White',\n"," 'Multiple groups, White; Black; Latino',\n"," 'Multiple groups, \"Primarily Caucasian\"',\n"," 'Multiple groups, 87.7% white, 9.7% black, 2.6% other',\n"," 'Multiple groups, 17 Caucasian, 2 Black',\n"," 'Multiple groups, Bulgarian and Roma participants',\n"," 'Multiple groups, Genotyped: 1669 White, 609 African American, 497 Hispanic, 127 Asian, 82 American Indian.',\n"," 'Multiple groups, 3 cohorts:A(75 self-reported Caucasions- Turin, Italy); B(42 self-reported Caucasians- Madrid, Spain); C(65 unknown, but probably mostly Caucasian since from Liverpool Therapeutic Drug Monitoring Registry).',\n"," 'Multiple groups, All the patients were white, apart from three (one Indian, one Yemeni, one half-Thai). All controls were white.',\n"," 'Oceanian',\n"," 'Multiple groups, Participants were of African American, Caucasian, Hispanic, Native North American or Other ethnicities. Note that 4 individuals reported having one Caucasian parent and one African American parent, while a further 5 reported having one Hispanic parent and one Caucasian parent. These individuals were classified as being African American or Hispanic, respectively.',\n"," 'Multiple groups, multi-site USA',\n"," 'Multiple groups, 77.4% White',\n"," 'Multiple groups, Black, White',\n"," 'Multiple groups, European, Asian Indian, African, indigenous Australian, Asian',\n"," 'Multiple groups, European American - Mainly White with some Latino/White',\n"," 'Multiple groups, Brazil: white and black',\n"," 'Multiple groups, 306 healthy Brazilians: 81 Euro-derived and 18 Afro-derived',\n"," 'Multiple groups, Canadian patients with European ancestry; (n=263) and non-Europeans (n = 81)',\n"," 'Custom, in vitro',\n"," 'Custom, HTCR (Human Tissue and Cell Research)',\n"," 'Multiple groups, Cases:  Recipients of  kidney transplants at the Oxford Transplant Centre.  95% were Caucasian.  The *1/*3C patient was of Afro-Caribbean ancestry.  The controls were UK Caucasian cadavers (renal allograft donors).',\n"," 'Multiple groups, Patients from 129 centers across 14 countries',\n"," 'Multiple groups, White, African American and other from Baltimore , MD.',\n"," 'Multiple groups, 93% of participants were white and 97% were non-Hispanic',\n"," 'Multiple groups, Caucasian, Afro-Caribbean, Indian/Asian',\n"," 'Multiple groups, Caucasian, Black, Hispanic/Latin.',\n"," 'Multiple groups, Japan',\n"," 'Multiple groups, 94% Caucasian, France and Belgium',\n"," 'Multiple groups, European or Latin American ancestry',\n"," 'Multiple groups, London UK, White Caucasian (32%), Black Caribbean (33%), Black African (24%), Asian/other (10%), no details',\n"," 'Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicitites. 13 participants did not give an ethnicity.',\n"," 'Multiple groups, 81% caucasian',\n"," 'Multiple groups, Caucasian, Black, Hispanic, Oriental, Missing',\n"," 'Multiple groups, 4 studies all listed as Caucasian; Italy, Spain, Norway, USA',\n"," 'Multiple groups, Caucasian, Asian, Black, Oriental, Mixed, Unknown',\n"," 'Multiple groups, mostly White patients(95% were White) patients at a Spanish hospital.',\n"," 'Multiple groups, 91% caucasian, 4.5% african american',\n"," 'Multiple groups, 95% White.',\n"," 'Multiple groups, (Hispanic or Latino,American Indian or Alaska Native(American Indian), Black or African American(African)(= Venezualan clinic patients))',\n"," 'Multiple groups, 89% white',\n"," 'Multiple groups, Asian (n=8), Black (n=7), Caucasian (n=120)',\n"," 'Multiple groups, Brazil, 70.5% White',\n"," 'Multiple groups, Predominantly European American patients.',\n"," 'Multiple groups,  Caucasian (76%), Asian (2%), African American (5%), Hispanic (11%), Other',\n"," 'Multiple groups, 78 African American and 65 white patients',\n"," 'Multiple groups, 139 Caucasians, 2 Black Africans',\n"," 'European',\n"," 'Multiple groups, African Americans and African populations',\n"," 'Multiple groups, 94 White;49  African American',\n"," 'Multiple groups, 225 Caucasians and 146 Blacks for nevirapine and efavirenz cohorts, Germany',\n"," 'Multiple groups, White (n = 34), Asian (n = 4) and Latino (n = 2)',\n"," 'Multiple groups, HIV infected White and Black patients from German Competence network for HIV/AIDS',\n"," 'Multiple groups, See Table 1',\n"," 'Multiple groups, USA: 20% Black, 70% white, 9% other; NCT00088452',\n"," 'Multiple groups, Mainly Caucasian, remainder unspecified',\n"," 'Multiple groups, White,African American,Hispanic,Asian/Pacific Islanders,American Indians.',\n"," 'Multiple groups, Boston, USA \"Over 35% of the participants came from ethnic minority populations\"',\n"," 'Multiple groups, 40% Africanâ¿¿American, 28% Caucasian (European), 19% Hispanic, 5% Asian, 8% other',\n"," 'Multiple groups, 85% were white.',\n"," 'Multiple groups, German, Kenyan parents.',\n"," 'Multiple groups, INVEST-GENES.  40% White; 48.4 % Hispanic; 11.7% Black. \"cohort study nested in a randomized trial.\"',\n"," 'Multiple groups, 100% Caucasian for *3/*3 patients; 56% for *1/*1 or *1/*3, 44% \"other\".',\n"," 'Multiple groups, 94% caucasian',\n"," 'Multiple groups, Singapore: Chinese, Malay, Indian, Other',\n"," 'Multiple groups, \"White, Black, Mulatto or Oriental\" participants from Brazil',\n"," 'Multiple groups, European American and African American participants',\n"," 'Multiple groups, Asian, European',\n"," 'Multiple groups, Participants self‐identified themselves as of African ancestry (black), Cape mixed ancestry, or Caucasian (white)',\n"," 'Multiple groups, INVEST-GENES: White, Black, Hispanic and mixed.',\n"," 'Multiple groups, mostly Caucasian.  Individual studies were conducted in Europe or North America.',\n"," 'Custom, Specified \"Han patients with epilepsy.\"',\n"," 'Multiple groups, From table 1, Ancestry: 72% European, 23% African, 5% Native American',\n"," 'Multiple groups, White, black, Hispanic and other ethnicities',\n"," 'Multiple groups, European-Brazilian and African-Brazilian',\n"," \"Multiple groups, White, Black and 'other' ethnicities\",\n"," 'Multiple groups, Malay, Chinese and other',\n"," 'Multiple groups, See Figure 1A for genetic ancestry data',\n"," 'Multiple groups, Chinese, Indian and Malay participants in Singapore',\n"," 'Multiple groups, Study carried out in Stockholm, Sweden. 120 controls and 67 cases had two Swedish parents and were included in subgroup analysis.',\n"," 'Multiple groups, 105 Caucasians (6 Hispanic or Latino),1 African-American,1 Asian',\n"," 'Central/South Asian',\n"," 'Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)',\n"," 'Multiple groups, Caucasian, Black, Asian',\n"," 'Multiple groups, 194 African Americans, 57 whites, 53 Latinos',\n"," 'Multiple groups, 6 Caucasians, 5 African-Americans.',\n"," 'Multiple groups, Irish, UK, Taiwan',\n"," 'Multiple groups, 89.8% White;7.9% North-African;1% Hispanic;0.6 % Asian.',\n"," 'Multiple groups, 87 white;2 African American; 3 Asian.',\n"," 'Multiple groups, \"majority Central Europeans, 9 subjects from Turkey, and 1 subject each from the Ukraine, Syria, Tunisia, Dubai, and Asia\"',\n"," 'Multiple groups, Participants were of Caucasian, African American or Asian background. Study carried out in Baltimore, Maryland.',\n"," 'Multiple groups, 96% white',\n"," 'Multiple groups, Two Whites and One Chinese from Singapore',\n"," 'Multiple groups, 227 African Americans and 219 European Americans',\n"," 'Multiple groups, Caucasians: 288;African-Americans:107;Other:17',\n"," 'Multiple groups, Chinese, Korean, French',\n"," 'Multiple groups, Authors list 41/49 Caucasian, 7/49 African American, 1/49 other.',\n"," 'Multiple groups, Asian, Black, White',\n"," 'Multiple groups, Caucasian (n=120), African (n=12), Asia (n=3).',\n"," 'Multiple groups, American: Caucasian, Asian, Hispanic',\n"," 'Multiple groups, Participants from studies carried out in China, India, Japan and Korea.',\n"," 'Multiple groups, 293 African American,1245 White Non-Hispanic, 241 White Hispanic.',\n"," 'Multiple groups, Caucasian, Asian',\n"," 'Multiple groups, Netherlands, Turkey, Sweden, Denmark, Finland, Italy',\n"," 'Multiple groups, 79.6% Caucasian;8.8% Hispanic;3.3% Asian;2.8% African-American; 5.2% undisclosed. Subjects were from the Denver/Boulder, CO metropolitan area.  About half the samples were from unrelated individuals and the other half were dizygotic twin and sib-pairs.',\n"," 'Multiple groups, meta-analysis one \"Han Chinese\", 2 \"Caucasians\", 1 \"Iranians\"',\n"," 'Multiple groups, Chinese, Malay and Indian self-reported ethnicities.',\n"," 'Multiple groups, South African. Mixed ancestry - San, Khoi-Khoi, European, Madagascan, West African, Javanese',\n"," 'Multiple groups, Japanese and Caucasian',\n"," 'Multiple groups, USA: 86% white',\n"," 'Multiple groups, Caucasian, African American and Other ethnicities.',\n"," 'Multiple groups, all cases were Caucasian, 4 of controls were non-Caucasian',\n"," 'Multiple groups, Mostly Caucasian, ranging from 88% white to 100% white cases, one study Korean Asian, one unknown,',\n"," 'Multiple groups, Chinese, Malay, Indian mixed population.',\n"," 'Multiple groups, Brazil, 85% White, 15% Others',\n"," 'Multiple groups, predominantly White',\n"," 'Multiple groups, 88 CEU HapMap cell lines; 89 Yorubi HapMap cell lines',\n"," 'Multiple groups, African, White, Hispanic, Asian',\n"," 'Multiple groups, French, Australian, UK',\n"," 'Multiple groups, Black, White, Hispanic',\n"," 'Multiple groups, predominantly white',\n"," 'Multiple groups, American Indian/Alaska Native Asian; Black or African American Multiple; White; Missing',\n"," 'Multiple groups, 22 Caucasians, 14 African-Americans',\n"," 'Multiple groups, mainly White',\n"," 'Multiple groups, \"ndividuals from two admixed populations were included in the discovery phase: the Genes-environments & Admixture in Latino Americans Study (GALA II) and the Study of African Americans,  Asthma,Genes  andEnvironments  (SAGE).\"',\n"," 'Multiple groups, Japanese and UK',\n"," 'Multiple groups, Australia, Belgium, Germany, New Zealand, USA CF centers',\n"," 'Multiple groups, White, Asian, Other',\n"," 'Multiple groups, 432 European American plus 25 African American',\n"," 'American',\n"," 'Multiple groups,  Cincinnati Children’s Hospital Medical Center self identified Caucasian and African American',\n"," 'Multiple groups, Caucasian, Asian, Other',\n"," 'Multiple groups, Caucasian, Asian, Latvian, Chilean, African-American',\n"," 'Multiple groups, The study was conducted by Celerion in Tempe, Arizona, USA',\n"," 'Multiple groups, White:21; African_American:14; Asian:7',\n"," 'Multiple groups, European Americans, African Americans, Other',\n"," 'Multiple groups, \"(93%) identified as genetically European\"',\n"," 'Multiple groups, Predominantly African American (67%)',\n"," 'Multiple groups, Caucasian, African, Unknown',\n"," 'Multiple groups, Self-identified Caucasian or African American ancestry',\n"," 'Multiple groups, USA: 73% White, 18.9% African American, 8.1% Asian',\n"," \"Multiple groups, Chinese, Indian, Malay and 'other' participants from Singapore\",\n"," 'Multiple groups, 206 unrelated non-Hispanic women (130 blacks and 76 whites)',\n"," 'Multiple groups, European American (n=734), African American (n=69), Asian (n=41), Other (n=38)',\n"," 'Multiple groups, White, Black, Asian, Pacific Islander, Native American, Unknown',\n"," 'Multiple groups, Non-Hispanic White, Asian, African American, Latino',\n"," 'Multiple groups, 93.2% White;2.4% Asian;1.0 % Black; 3.4% other.',\n"," 'Multiple groups, 97% African American, 3 Hispanic, 1 Caucasian',\n"," 'Multiple groups, 82 South African Colored (SAC), 13 Xhosa and eight Caucasian individuals',\n"," 'Multiple groups, \"Hispanic Caucasian\" and \"Non-Hispanic Caucasian\" subjects',\n"," 'Multiple groups, Swedish, Turkish and Chinese',\n"," 'Multiple groups, Predominantly White European (95%)',\n"," 'Multiple groups, Mostly Caucasian, remainder unspecified',\n"," 'Multiple groups, 95% White, 2% Black, 4% other',\n"," 'Multiple groups, 184 sites in the U.S.; Puerto Rico.  Whites,Hispanics.',\n"," 'Custom, Not applicable - study carried out in Xenopus oocytes',\n"," 'Multiple groups, White, Black and Hispanic',\n"," 'Multiple groups, USA : White (314), Black (19),  other (17)',\n"," 'Multiple groups, \"1474 participants (41.4%) of; non-European genetic ancestry, including 284 of African ancestry (8.0%), 781 of admixed American; and Latino ancestry (22.0%), 142 of Asian ancestry (4.0%), and 267 other ancestry\"',\n"," 'Multiple groups, CIN cohort is from China, CIAC is European',\n"," 'Multiple groups, Participants were African American or non-Hispanic white',\n"," \"Multiple groups, Caucasian and 'Other' ethnicities.\",\n"," 'Multiple groups, 98% Caucasian and 2% Asian',\n"," 'Multiple groups, 85 White and 69 Black individuals',\n"," 'Multiple groups, 48 European Americans; 4 African Americans; 2 Hispanics',\n"," 'Multiple groups, White, Black, other',\n"," 'Multiple groups, USA, Caucasian and African-American men and women',\n"," 'Multiple groups, Not stated: studies in Belgium, Switzerland, Denmark, Czech, China and Greece.',\n"," 'Custom, in-vitro',\n"," 'Multiple groups, 87.8% white, 7% black, 2.7% hispanic, 1.8% asian, 0.6% other.; 79.3% male',\n"," 'Multiple groups, Caucasian, African, Asian',\n"," 'Multiple groups, Portugal: 44 white, 1 african',\n"," 'Multiple groups, White, African American, Hispanic, Asian',\n"," 'Multiple groups, Caucasian, African, Asian, Other, Not stated',\n"," 'Multiple groups, Europe, UK, US, Australia',\n"," 'Multiple groups, Caucasian, Asian or other ethnic background',\n"," 'Multiple groups, 94% white, 6% Black or African American',\n"," 'Multiple groups, 2 self-reported African American ancestry; 1 self-reported Pacific Islander ancestry; the remainder self-reported as White.',\n"," 'Multiple groups, Netherlands, 97% Caucasian',\n"," 'Multiple groups, Cases and controls were \"primarily Caucasian\".',\n"," 'Multiple groups, Women were from all parts of Canada and most were White(\"6 cases and 10 controls were of non-Caucasian ethnicity\").',\n"," 'Multiple groups, Framingham MA, USA, random sample of population',\n"," 'Multiple groups, UK Biobank',\n"," 'Multiple groups, Caucasian, East Asian, South Asian, Black, Other',\n"," 'Multiple groups, European, Asian, Other',\n"," 'Multiple groups, \"93.2% Caucasian\"',\n"," 'Multiple groups, 2 Black, 1 Asian, 9 Whites',\n"," 'Multiple groups, USA St Jude, specified 43 white, 13 black and 12 other.',\n"," 'Multiple groups, pooled African American plus European subjects,  mainly from the mid-south U.S states (part of  the MSTF= Mid-South Tobacco Family) cohort.',\n"," 'Multiple groups, Primarily European, African, some Hispanic, Asian Pacific, American Indian',\n"," 'Multiple groups, 92.9% White, Connecticut USA',\n"," 'Multiple groups, Majority of participants were Caucasian',\n"," 'Multiple groups, 94 patients were of white Spanish origin, one was of African (Moroccan) origin, and one was of Asian (Indian) origin',\n"," 'Multiple groups, European and US',\n"," 'Multiple groups, 278 white patients and 95 black patients; 293 male',\n"," 'Multiple groups, Brazilian participants (white, black, intermediate, Asian or Amerindian).',\n"," 'Multiple groups, 621 African American and European American families from 4 U.S. sites',\n"," 'Multiple groups, Caucasian, Indigenous Australian and Asian participants',\n"," 'Multiple groups, African America, Asian, Hispanic, White',\n"," 'Multiple groups, 85% Both parents of European origin',\n"," 'Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage.',\n"," 'Multiple groups, White and African American participants',\n"," 'Multiple groups, Excerpt from paper: \"All of the patients were considered as pure Filipinos except for five patients (one case and four tolerant controls) who were considered as mixed Filipinos. One case and two tolerant controls have Chinese descent. The other tolerant controls have German, Indian, and Spanish lineage.\"',\n"," 'Multiple groups, Studies that included patients with European, Asian and African ancestry were included in the meta-analysis.',\n"," 'Multiple groups, Caucasians (n=46), African Americans (n=10)',\n"," 'Multiple groups, Mostly European samples',\n"," 'Multiple groups, Mostly Caucasian and Asian',\n"," 'Multiple groups, USA, about 80% White, 10-20% African American, a couple of Asian and HIspanic subjects',\n"," 'Multiple groups, USA Michigan and Indiana Universities, 88% white, 9% black, 3% other.',\n"," 'Multiple groups, White, African-American, Native Hawaiian',\n"," 'Multiple groups, Caucasian and Asian subjects',\n"," 'Multiple groups, combined European American and African American sample',\n"," 'Multiple groups, For all genotypes, there were 7907 subjects.  5749 were \"*1/*1\";24 were *3/*3 (the rest were other genotypes). 12 studies were performed in Asia,13 in the Americas and 14 in Europe.',\n"," 'Multiple groups, White, Black, Hispanic, Asian, Other',\n"," 'Multiple groups, White and black subjects',\n"," 'Multiple groups, population comprised whites, african american, asian and hispanics',\n"," 'Multiple groups, Jewish. Jewish Israeli, 44-57% Ashkenazi',\n"," 'Multiple groups, 30 Caucasian, 5 African',\n"," 'Multiple groups, 67 Caucasian, 3 Hispanic',\n"," 'Multiple groups, Malay, Chinese, Indian',\n"," 'Multiple groups, \"White and Other ethnicities\"',\n"," 'Custom, Not applicable - study carried out in BHK cells',\n"," 'Custom, cell lines',\n"," \"Multiple groups, 1416 patients in the cohort were white, 285 were black and 114 were classed as 'other'\",\n"," 'Multiple groups, Caucasian: 69%, African American: 20%, Asian: 7.7%, Native American: 1.7% and Unknown: 1.9%.',\n"," 'Multiple groups, Majority of patients were Caucasian.',\n"," 'Multiple groups, Caucasians, African Americans, Asians and Hispanics',\n"," 'Multiple groups, Three of them were conducted in China, two in the U.S.A., one in Canada, one in Finland, and one in Korea. Six of them were cohort studies, and two were randomized controlled trials.',\n"," 'Multiple groups, Japanese American, European American, Native Hawaiian',\n"," 'Multiple groups, Caucasian and White',\n"," 'Multiple groups, 25 black/African American, 4 Asian, 2 North American Native, 68 Hispanic and Non-Hispanic white.',\n"," 'Multiple groups, Some participants were of non-European ancestry.',\n"," 'Multiple groups, Caucasian, Native American, African American, Asian',\n"," 'Multiple groups, 46 Caucasian subjects, one Latino subject',\n"," 'Multiple groups, Forty-five patients were Caucasian, 3 Asian, 3 African-American and 2 Hispanic',\n"," 'Multiple groups, Ashkenazi Jewish origin, Sephardic Jewish origin, Mixed Jewish origin (Ashkenazi + Sephardic), any other origin',\n"," 'Multiple groups, Caucasians and Latin Americans',\n"," 'Multiple groups, 53% White, 42% Polynesian (Maori), 5% Asian',\n"," 'Multiple groups, Majority of patients were Caucasian and not of Hispanic/Latino origin',\n"," 'Multiple groups, mostly Blacks, Whites',\n"," 'Multiple groups, China, Japan, India, Singapore, Uruguay, Thailand',\n"," 'Multiple groups, Asian populations, including Thais, Han Chinese, Malays, and Indians',\n"," 'Multiple groups, USA, Seattle, predominantly White 1-3% Black',\n"," 'Multiple groups, Italy, Caucasian (n=11), African (n=7), Asian (n=3), Latin American (n=3)',\n"," 'Multiple groups, meta-analysis one \"Han Chinese\", 2 \"Caucasians\",',\n"," 'Multiple groups, Although the cohort is treated by the authors as a Caucasian population, people of Asian and African origin are included as cases.',\n"," 'Multiple groups, Liver Donors were Northern European,African,Hispanic, Other or Unknown.  A subset was used for genotyping.',\n"," 'Multiple groups, Asian, African American, Hispanic, Caucasian and Other ethnicities.',\n"," 'Multiple groups, HapMap CEU and YRI cell lines',\n"," 'Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil',\n"," 'Multiple groups, African (n=6), European (n=23), Hispanic (n=2), multiple race (n=2)',\n"," 'Multiple groups, Asian, Thai, Black, White',\n"," 'Multiple groups, Caucasian, Asian, Native American, Other',\n"," 'Multiple groups, \"12 African-American/Black, 18 Caucasian/White, 3 Multiracial, 1 Native-American or Alaskan, 2 chose not to report.; Ethnically, 22% of the sample identified as Hispanic or Latino.\"',\n"," 'Multiple groups, White and Unknown',\n"," 'Multiple groups, Framingham MA, USA, random population sample',\n"," 'Multiple groups, Studies from China, Germany',\n"," 'Multiple groups, White, African American, Asian American and/or Pacific Islander, Hispanic or Other ethnicities',\n"," 'Multiple groups, Brazilian.',\n"," 'Multiple groups, Developed osteonecrosis: 45 White;2 Black; 4 Hispanic.  Did not develop osteonecrosis: 212 White;28 Black;55 Hispanic;15 Other.',\n"," 'Multiple groups, Study carried out in hospitals in Miami, Florida and Jerusalem, Israel. Participants were predominantly of Jewish, Arab, Black or Hispanic ethnicities.',\n"," 'Multiple groups, mostly White',\n"," 'Multiple groups, African American and Caucasian.',\n"," 'Multiple groups, 111 were Caucasian American and 99 were African American',\n"," 'Multiple groups, Study included Swedish, European American, Finnish, American Indian, African American, German, Hispanic, Japanese, Korean, Chinese, Taiwanese, Indian and Malay participants.',\n"," 'Multiple groups, \"Southern United States\"',\n"," 'Multiple groups, Singapore',\n"," 'Multiple groups, Los Angeles, Hispanic (n = 89), Non-Hispanic (n = 54), age of patients ranged from < 1–20 years',\n"," \"Multiple groups, White,Black,Asian,American Indian children treated at St. Jude's Hospital.  Uncorrected p was 1.8 x 10 (-5).  364,033 SNPs were tested, so a Bonforroni corrected p would not be < 0.05\",\n"," 'Multiple groups, East Asian (n=188) and Caucasian (n=147)',\n"," 'Multiple groups, mostly White, with some African American,Asian Pacific Islander,Hispanic, and other.',\n"," 'Multiple groups, 68% Caucasian, 18% African American, 1% Asian, 2% Other',\n"," 'Multiple groups, Singapore (Chinese, Malay, Indian)',\n"," 'Multiple groups, 65 patients qualified for pharmacogenomic studies, 46 were of East Asian ethnicity and 19 were of non-Asian ethnicity (18 Hispanic and one Caucasian)',\n"," 'Multiple groups, 74% Caucasian',\n"," 'Multiple groups, white, African; American, and Hispanic men and women with hypertension',\n"," 'Multiple groups, white, black, other',\n"," 'Multiple groups, southern Brazilian population, 81% of European ancestry',\n"," 'Multiple groups, Caucasian (n=178), Middle Eastern (n=2), Asian (n=5), Other (n=4).',\n"," 'Multiple groups, 98% ethnic Germans',\n"," 'Multiple groups, White, African American, Asian, Unknown',\n"," 'Multiple groups, 30/36 patients were of African origin (countries of origin: Burundi, Eritrea, Ethiopia, Sudan, Ivory Coast, Kenya, Liberia, Rwanda, Somalia, Tanzania and Uganda), 4/36 were of Asian origin (countries of origin: India, Philippines, Thailand and Uzbekistan) and 2/36 were of Latin American origin (countries of origin: Chile and Honduras)',\n"," 'Multiple groups, Caucasian, East Asian, Undeclared',\n"," 'Multiple groups, Asian and Caucasian',\n"," \"Multiple groups, 86.4% White, non-Hispanic;3.4% White, Hispanic; 10.2% Black, non-Hispanic followed at Children's Hospital of Pittsburgh (PA, USA)\",\n"," 'Multiple groups, Region of enrollment: (original TRITON-TIMI 38 paper) North America; Western Europe; Eastern Europe; Middle East; Africa; Asia; Pacific',\n"," 'Multiple groups, 85% of participants were of European ethnicity',\n"," 'Central/South Asian, African American/Afro-Caribbean',\n"," 'Multiple groups, Caucasian, African American, Asian and multiracial patients',\n"," ...]"]},"execution_count":75,"metadata":{},"output_type":"execute_result"}],"source":["biogroups = list(set(df[\"biogroup\"]))\n","biogroups"]},{"cell_type":"code","execution_count":76,"metadata":{},"outputs":[{"name":"stdout","output_type":"stream","text":["32076\n","26.315625389699466\n","7.3232323232323235\n","23515\n","35.896236444822456\n","9.989368488199021\n"]}],"source":["total = len(df)\n","print(total)\n","df_ = df.dropna(subset=['biogroup']) #remove empty to apply mask\n","afr = len(df_[df_[\"biogroup\"].str.contains(\"African\")])\n","eur = len(df_[df_[\"biogroup\"].str.contains(\"European\")])\n","print((eur/total)*100)\n","print((afr/total)*100)\n","\n","df2_ = df_[df_[\"biogroup\"]!=\"Unknown\"] #remove cases where the biogrup is unknown\n","total_known = len(df2_)\n","print(total_known)\n","afr = len(df2_[df2_[\"biogroup\"].str.contains(\"African\")])\n","eur = len(df2_[df2_[\"biogroup\"].str.contains(\"European\")])\n","print((eur/total_known)*100)\n","print((afr/total_known)*100)"]},{"cell_type":"markdown","metadata":{},"source":["# UK Biobank\n","\n","Data comes directly from their publication:\n","* 94.6% European\n","* 1.6% African"]},{"cell_type":"markdown","metadata":{"id":"ONssqrEeY1BJ"},"source":["## Plot as barplot"]},{"cell_type":"code","execution_count":null,"metadata":{},"outputs":[],"source":[]},{"cell_type":"code","execution_count":68,"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":472},"executionInfo":{"elapsed":1241,"status":"ok","timestamp":1699438832483,"user":{"displayName":"Gemma Turon","userId":"16230368266280330675"},"user_tz":-60},"id":"w2WqWI93YtU7","outputId":"e94c5bde-dffb-4f5a-9d7d-c83e37ae9624"},"outputs":[{"data":{"image/png":"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","text/plain":["<Figure size 640x480 with 1 Axes>"]},"metadata":{},"output_type":"display_data"}],"source":["import matplotlib.pyplot as plt\n","\n","data = {\n","    'GWAS Catalog': [76.3, 22.89],\n","    'UK Biobank': [94.6, 1.6],\n","    'PharmGKB': [35.89, 9.99]\n","}\n","\n","databases = list(data.keys())\n","eur_percentages = [value[0] for value in data.values()]\n","afr_percentages = [value[1] for value in data.values()]\n","\n","# Create an array for the x-axis positions\n","x = range(len(databases))\n","\n","# Width of each bar\n","bar_width = 0.35\n","\n","# Create the bar plot\n","plt.bar(x, eur_percentages, width=bar_width, label='European Ancestry', align='center', color = \"#50285a\")\n","plt.bar([i + bar_width for i in x], afr_percentages, width=bar_width, label='African Ancestry', align='center', color = \"#faa08c\")\n","\n","# Set x-axis labels\n","plt.xticks([i + bar_width/2 for i in x], databases)\n","\n","# Add labels and legend\n","plt.xlabel('Databases')\n","plt.ylabel('Percentage')\n","plt.title('Percentage of EUR and AFR in Different Databases')\n","plt.legend()\n","\n","# Show the plot\n","plt.show()\n"]},{"cell_type":"code","execution_count":69,"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":430},"executionInfo":{"elapsed":491,"status":"ok","timestamp":1699438897469,"user":{"displayName":"Gemma Turon","userId":"16230368266280330675"},"user_tz":-60},"id":"oMHNA0TlZQ6L","outputId":"c41e5f1f-e04e-4c0f-d9d6-53c902d54269"},"outputs":[{"data":{"image/png":"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","text/plain":["<Figure size 640x480 with 1 Axes>"]},"metadata":{},"output_type":"display_data"}],"source":["import matplotlib.pyplot as plt\n","\n","data = {\n","    'GWAS Catalog': [76.3, 22.89],\n","    'UK Biobank': [94.6, 1.6],\n","    'PharmGKB': [35.89, 9.99]\n","}\n","\n","databases = list(data.keys())\n","eur_percentages = [value[0] for value in data.values()]\n","afr_percentages = [value[1] for value in data.values()]\n","\n","# Create an array for the x-axis positions\n","x = range(len(databases))\n","\n","# Create the dot plot for EUR percentages\n","plt.scatter(x, eur_percentages, marker='o', label='European', color='#50285a')\n","\n","# Create the dot plot for AFR percentages\n","plt.scatter(x, afr_percentages, marker='o', label='African', color='#faa08c')\n","\n","# Draw horizontal lines connecting the EUR and AFR percentages\n","plt.plot(x, eur_percentages, linestyle='--', color='#50285a')\n","plt.plot(x, afr_percentages, linestyle='--', color='#faa08c')\n","\n","# Set x-axis labels\n","plt.xticks(x, databases)\n","\n","# Add labels and legend\n","plt.ylabel('Percentage of studies (%)')\n","plt.legend()\n","\n","# Show the plot\n","plt.show()"]},{"cell_type":"code","execution_count":70,"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"executionInfo":{"elapsed":925,"status":"ok","timestamp":1699439345608,"user":{"displayName":"Gemma Turon","userId":"16230368266280330675"},"user_tz":-60},"id":"SP9ECuCHeBzB","outputId":"d4f015b4-873c-4948-895d-58f69dd6cb05"},"outputs":[{"data":{"text/plain":["<matplotlib.legend.Legend at 0x2a2367fd0>"]},"execution_count":70,"metadata":{},"output_type":"execute_result"},{"data":{"image/png":"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","text/plain":["<Figure size 345x345 with 1 Axes>"]},"metadata":{},"output_type":"display_data"}],"source":["import stylia as st\n","\n","fig, axs = st.create_figure(1,1)\n","ax = axs[0]\n","\n","data = {\n","    'GWAS Catalog': [76.3, 22.89],\n","    'UK Biobank': [94.6, 1.6],\n","    'PharmGKB': [35.89, 9.99]\n","}\n","\n","databases = list(data.keys())\n","eur_percentages = [value[0] for value in data.values()]\n","afr_percentages = [value[1] for value in data.values()]\n","\n","# Create an array for the x-axis positions\n","x = range(len(databases))\n","# Create the dot plot for EUR percentages\n","ax.scatter(x, eur_percentages, marker='o', label='European', color='#50285a')\n","# Create the dot plot for AFR percentages\n","ax.scatter(x, afr_percentages, marker='o', label='African', color='#faa08c')\n","\n","# Draw horizontal lines connecting the EUR and AFR percentages\n","ax.plot(x, eur_percentages, linestyle='--', color='#50285a')\n","ax.plot(x, afr_percentages, linestyle='--', color='#faa08c')\n","\n","# Set x-axis labels\n","ax.set_xticks(x, databases)\n","\n","# Add labels and legend\n","ax.set_ylabel('Percentage of studies (%)')\n","ax.set_title(\"\")\n","ax.set_xlabel(\"\")\n","plt.legend()"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"nmoRD3Y1eRkj"},"outputs":[],"source":[]}],"metadata":{"colab":{"authorship_tag":"ABX9TyMEim8ksccy+e1dHO5Eqi6I","provenance":[]},"kernelspec":{"display_name":"Python 3","name":"python3"},"language_info":{"codemirror_mode":{"name":"ipython","version":3},"file_extension":".py","mimetype":"text/x-python","name":"python","nbconvert_exporter":"python","pygments_lexer":"ipython3","version":"3.11.8"}},"nbformat":4,"nbformat_minor":0}
